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APPROACHES TO ENHANCE INTERPRETABILITY AND MEANINGFUL USE 
OF BIG DATA IN POPULATION HEALTH PRACTICE AND RESEARCH 
KOMAL PEER 
Boston University School of Public Health, 2021 
Major Professor: M. Patricia Fabian, ScD, Associate Professor of Environmental Health 
ABSTRACT 
While many public health and medical studies use big data, the potential for big 
data to further population health has yet to be fully realized. Because of the complexities 
associated with the storage, processing, analysis, and interpretation of these data, few 
research findings from big data have been translated into practice. Using small area 
estimation synthetic data and electronic health record (EHR) data, the overall goal of this 
dissertation research was to characterize health-related exposures with an explicit focus 
on meaningful data interpretability. In our first aim, we used regression models linked to 
population microdata to respond to high-priority needs articulated by our community 
partners in New Bedford, MA. We identified census tracts with an elevated percentage of 
high-risk subpopulations (e.g., lower rates of exercise, higher rates of diabetes), 
information our community partners used to prioritize funding opportunities and 
intervention programs. In our second and third aims, we scrutinized EHR data on 
children seen at Boston Medical Center (Boston, MA), New England’s largest safety-net 
hospital, from 2013 through 2017 and uncovered racial/ethnic disparities in asthma 
severity and residential mobility using logistic regression. We built upon a validated 
asthma computable phenotype to create a computable phenotype for asthma severity that 
 
ix 
is based in clinical asthma guidelines. We found that children for whom severity could be 
ascertained from these EHR data were less likely to be Hispanic and that Black children 
were less likely to have lung function testing data present. Lastly, we constructed 
contextualized residential mobility and immobility metrics using EHR address data and 
the Child Opportunity Index 2.0, identified opportunities and challenges EHR address 
data present to study this topic, and found significant racial/ethnic disparities in access to 
neighborhood opportunity. Our findings highlighted the perpetuation of residence in low 
opportunity areas among non-White children. The main challenge of this dissertation, to 
work within the limitations inherent to big data to extract meaningful knowledge from 
these data and by linking to external datasets, turned out to be an opportunity to engage in 
solutions-oriented research and do work that, to quote Aristotle, “…is greater than the 
sum of its parts”. Through strategies ranging from engaging with community partners to 
examining who and what data are captured (and not captured) in EHR health and address 
data, this dissertation demonstrated potential ways to leverage big data sources to further 
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CHAPTER 1. INTRODUCTION 
Big data and public health 
Big data is transformative in many fields, but can make a difference for health. A 
most timely and significant example is its role in combating the current Coronavirus 
Disease 2019 (COVID-19) pandemic. Thus far, big data has been used to detect, monitor, 
and control COVID-19 spread1; to understand symptomology and outcomes2; to inform 
drug and vaccine development, safety, and efficacy3; and, to identify racial/ethnic and 
socioeconomic health disparities4,5 to inform resource allocation and protect vulnerable 
populations. Additional examples from practice more broadly include the development of 
recommendation systems in healthcare, epidemic surveillance, food safety monitoring, 
chronic disease monitoring, genomic studies, and precision health.6–10  
There are also numerous studies that have utilized electronic health record (EHR) 
data to conduct epidemiologic studies that are cross-sectional, longitudinal, and 
incorporate place-based data by linking to external datasets (such as air pollution, green 
space, segregation measures, or census data) to examine relationships between social, 
physical, and built environments and health or healthcare use.11,12 Current day big data 
sources utilized in public health research and practice include information from 
healthcare (electronic health records, insurance claims, pharmaceutical), 
socioenvironmental data (census, police records, chemical or air pollution exposure 
models), smart devices (phones and watches), and the internet (social media.) These data 
are often collected in real-time or shortly thereafter and include time (date-time stamps) 




Big data is a term that has gained popularity over the recent decades, is used 
across a variety of sectors, and as a result has many definitions and may refer to more 
than one concept. In 2015, The National Institute of Standards and Technology (NIST) 
issued a report to clarify concepts and definitions relevant to big data and data science—a 
field that is now relevant to almost every discipline and cuts across industry, government, 
and academia.13 NIST’s definition is as follows: “Big data consists of extensive 
datasets—primarily in the characteristics of volume, variety, velocity, and/or 
variability—that require a scalable architecture for efficient storage, manipulation, and 
analysis.”13 Volume refers to the scale of data, variety refers to the different forms of data 
(e.g., structured and unstructured data), velocity refers to the analysis of streaming data, 
and veracity refers to uncertainty (i.e., quality) of data. 14  
Despite the wealth of big data sources and advances, the full potential of big data 
to further public health has yet to be realized,15–17 including combating the COVID-19 
pandemic.18  Researchers and practitioners in healthcare, public health, and medicine are 
conducting studies to discover and innovate using big data, however very few research 
findings from big data have been translated into clinical knowledge or clinical practice.19 
The field of environmental health, from epidemiology to high-throughput toxicology, 
continues to grapple with the challenges of gleaning insight from big data investigations20 
as well as understanding the impact of various methodologies, linked data sources, and 
residual confounding and bias.12 As evidenced by NIH’s Office of Strategic Coordination 
- The Common Fund’s Big Data to Knowledge (BD2K) Program, developing innovative 




is a national priority since extracting useful knowledge from big data remains a major 
limiting factor to understanding health and disease.21  
Today, questions relevant to volume, variety, and velocity are: how do we collect, 
process, store, query, analyze, and extract meaning from relevant data within big data? 
Veracity speaks to the fact that the quality of the results and conclusions drawn from the 
data will be dictated by the quality of the underlying data.22 Veracity is the most 
important aspect of big data to understand when conducting empirical and applied health 
research. The two types of big data relevant to the aims carried out in this dissertation are 
small area estimation synthetic data and EHR data. The main challenge of this 
dissertation was to work within the limitations inherent to big data and acknowledge 
there is no one size fits all approach. The main excitement was to embrace the 
opportunity to engage in creative, collaborative, and cross-disciplinary thinking to further 
meaningful knowledge beneficial to health.  
Synthetic data: small area estimation data   
While synthetic data are useful across many sectors of society, they serve a 
particularly important role in the public domain as evidenced by investments made in 
their development and dissemination by the United States Census Bureau and NIST 
within the last decade.23,24 They are even more relevant to the healthcare field as 
demonstrated by the current funding of the development of synthetic EHR data by The 
Office of the National Coordinator for Health Information Technology (ONC).25 
Synthetic datasets are datasets in which all or some variables are generated using 




distributions. The main appeal of synthetic data are that they allow for dissemination of 
high quality data that can inform public health research, decision-making, and policy 
while preserving participant/patient confidentiality that is protected by law.23,26  
Specifically, small area estimation synthetic data are modeled statistical data 
generated from a larger geography for a smaller geography (e.g., census tract data 
modeled from county data.) Small area estimation synthetic data are most relevant to 
environmental health, population health surveillance, and local public health research and 
practice. Limited data relevant to health have historically been available at county and 
metropolitan levels, but not at a geographic scale meaningful to local public health 
initiatives such as the census tract or city-level.27 To address this need, the US Centers for 
Disease Control and Prevention (CDC) released high quality, small area synthetic data 
for 500 cities across the US for the first time in 2017 as part of its 500 Cities Project and 
expanded its data release for the entirety of the US in 2020 as part of its PLACES 
Project.28 Excitingly, synthetic data are growing in popularity, development, and 
accessibility, but they nonetheless require significant technical expertise and 
collaboration to produce as well as use.29 
EHR data: health data 
 While documentation of patient medical data has occurred as far back as ancient 
Egypt, documentation of medical data in EHR systems is a rather modern phenomenon 
that preliminarily began in the 1960s and 1970s.30 It is only in the last five years that 
adoption of EHR systems from paper records in the United States has been considered 




adopted a government certified EHR.32 While widespread adoption was largely driven by 
the financial incentives created by the Meaningful Use Program of the 2009 Health 
Information Technology for Economic and Clinical Health (HITECH) Act, the result was 
that we are now increasingly poised as a society to fully leverage these low-cost big data 
sources of detailed longitudinal health data to conduct unprecedented public health 
research.11,31,33 However, EHRs contain structured data (e.g., billing or procedure codes, 
lab results) and unstructured data (physician notes) designed and collected for clinical 
care and medical billing purposes, not research purposes. Not only do EHR systems vary 
significantly in regards to their structure, and clinician use31, the quality of the data stored 
in EHRs may not be sufficient for research purposes without careful considerations.34–38  
To aid in attenuating data quality concerns, the use of computable phenotypes has 
increased in popularity39–41, the concept of informed presence has come to fruition42,43, 
and interdisciplinary collaboration has become necessary for progress.44 The Phenotypes, 
Data Standards, and Data Quality Core of the NIH Health Care Systems Research 
Collaboratory defines a computable phenotype as “a clinical condition or characteristic 
that can be ascertained via a computerized query to an EHR system or clinical data 
repository using a defined set of data elements and logical expressions so as to be able to 
identify patients from clinical data for research purposes.”45,46 The intended goal of 
phenotyping is to re-purpose clinical and billing data in a reliable, reproducible, and 
transportable manner for large scale health research and many phenotypes are 
disseminated on The Phenotype Knowledgebase website, www.PheKB.org.47  




the underlying disease that researchers are interested in studying, but rather the totality of 
complex patient, clinician, and health system interactions and documentation (or lack 
thereof)48—a recent concept that has been termed informed presence.42,43 In other words, 
EHR data are not missing at random. Unless mitigated, the potential for bias and lack of 
validity when EHR data is used as an outcome or exposure measure in health research 
may be attributed to informed presence bias49–52. Excitingly, the epidemiological, data 
science, and informatics literatures are coalescing to create interdisciplinary solutions for 
big data health research.43,53,54 Researchers have demonstrated traditional approaches53,55 
as well as new creative approaches that leverage thinking from disciplines outside public 
health.36,54,56 This cross-disciplinary collaboration is the key to extracting meaningful 
knowledge from big data to further our understanding health and disease.  
EHR data: address data 
Largely driven by the decades of development, research, financial incentives, and 
government acts to advance healthcare, significant progress has been made on the  
volume, variety, velocity, and veracity (The 4 V’s of big data) of health data in EHRs, as 
described in the previous section. Richness of health data aside, EHRs also contain high 
resolution addresses data (current and historical addresses.) Address data in the EHR 
generally reflects information provided by patients at the time of an office visit as part of 
the registration process or from the billing portion of the EHR system. It is based on this 
information that geospatial data can be assigned at either low or high resolution (e.g., 
county level or address parcel) for research or practice purposes.  




environmental health literature. However, deliberate examination of residential mobility 
is largely limited to its potential role in exposure misclassification57–59 despite the 
established literature on environmental health disparities in housing (inclusive of housing 
instability)60–63 and on the co-location of social stressors and environmental hazards.64–66 
From a practice perspective, the potential of exploiting linked geospatial data is immense. 
As examples, real-time risk identification of issues such as mold removal from an 
asthmatic patient’s home could trigger intervention based simply on a patient’s address67 
or vulnerable patients who may be moving from one poor environment (housing or 
neighborhood) to another could be easily identified.   
While linking health data in the EHR to external datasets based on address data in 
the EHR has led to a wealth of studies and knowledge11,12,68–71, unlike the health data, 
less is known about the 4 V’s of the address data. Despite findings on neighborhood 
exposures and health documented by these studies, the predictive promise of 
neighborhood measures to improve health and healthcare have not followed.72–74 To our 
knowledge, only one small-scale study to date has examined the validity and reliability of 
address data in the EHR.75 Additionally, a recent systematic review found several gaps in 
the current literature on place-based health research using EHR data: 62% of EHR-based 
studies did not report information on methods used to assign geospatial data, and only 
40% of studies made limited use of historical records of residential addresses in the 
EHR.12 Lastly, while the concept of informed presence is studied in regards to EHR 
health data, it is lacking in relation to EHR address data. Informed presence is likely 




and if residential instability itself is a health risk factor or poses challenges in access to or 
continuity of care76, EHR address data too are not missing at random. Despite the nascent 
understanding and the current limitations of EHR address data, progress will ensue if the 
impact of the 4 V’s of big data is considered appropriately in study design and analyses.    
Dissertation goal and aims 
Illustrated throughout this chapter, informed use of synthetic data and EHR data as 
well as collaboration were central to conducting this dissertation. The overall goal of 
this dissertation research was to characterize health-related exposures (behavioral, 
clinical, and socioenvironmental) using big data sources with an explicit focus on 
meaningful data interpretability given the numerous limitations of these data. 
Through strategies ranging from engaging with community partners (Chapter 2) to 
examining the impact of informed presence (Chapter 3) to careful construction of 
exposure metrics based on EHR address data (Chapter 4), we demonstrate ways to 
meaningfully use and interpret big data sources to foster health and health equity. The 
three aims and gaps this research addresses are outlined below and Chapter 5 summarizes 
the findings of this research and provides a discussion of limitations, public health 
implications, and directions for future research.   
Chapter 2 aim (synthetic data): Connect small-area estimation synthetic data 
methods with high-priority needs articulated by community partners in a fully 
collaborative context to further local public health practice. There exists a real need 
to characterize patterns of risk factors within communities at a resolution that is 




research group’s development and use of small area estimation synthetic data pre-dates 
CDC’s innovative 500 Cities and PLACES projects.77 While studies conducted by other 
researchers provided important insights at a high geographic resolution78–82, these spatial 
microsimulation methods have not typically been developed or applied to respond 
directly to community members’ or community-serving organizations’ needs. To our 
knowledge, Chapter 2 is the first application that has connected spatial microsimulation 
methods with high-priority needs articulated by the community in a collaborative context. 
Chapter 3 aim (EHR health data): Create and evaluate a standardized pediatric 
asthma severity phenotype based in clinical asthma guidelines for use in EHR-based 
health initiatives and studies, and examine the impact of informed presence on these 
data. EHR data need to be extracted, readied and fully understood prior to conducting 
valid and interpretable health research. Standardized ascertainment of asthma severity 
status from EHR data is important to tackle because asthma severity is: 1) integral to an 
asthma diagnosis and treatment plan in the clinical setting; 2) a key element of valid and 
interpretable  research; 3) highly associated with significant economic burden nationally 
and internationally83–85; 4) relevant to advancing risk prediction of asthma morbidity and 
mortality.86–89 Chapter 3 builds off of an asthma computable phenotype that exists in the 
literature.90,91 To our knowledge, no validated and standardized computable phenotype 
that is based on clinical asthma guidelines exists for asthma severity.92,93 
Chapter 4 aim (EHR address data): Enrich the conceptualization and 
operationalization of residential mobility and explore one such operationalization 




EHR address and demographic data. EHR address data present an opportunity to 
explore residential mobility. This study was undertaken because heterogeneity between 
and within movers and non-movers is underexplored in the health literature.94,95 Morris et 
al. (2018) identified and thoroughly discussed key shortcomings that need to be improved 
to advance the residential mobility health literature: how mobility is categorized (i.e., the 
theoretical basis), the influence of time and critical periods, as well as the context of 
moves and the nature of residential moves as positive or negative experiences.95 
Similarly, Coulter et al. (2016) emphasized the importance of residential immobility as an 
active process, like residential mobility, that needs to be explored in-depth.94 Chapter 4 
explores residential mobility and immobility within and across neighborhood opportunity 
contexts in relation to demographic characteristics among children, and does so within 
the current limitations of EHR address data. To our knowledge, Chapter 4 is the first 
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Many health risk factors are intervention targets within communities, but information 
regarding high-risk subpopulations is rarely available at a geographic resolution that is 
relevant for community-scale interventions. Researchers and community partners in New 
Bedford, Massachusetts (USA) collaboratively identified high-priority behaviors and 
health outcomes of interest available in the Behavioral Risk Factor Surveillance System 
(BRFSS). We developed multivariable regression models from the BRFSS explaining 
variability in exercise, fruit and vegetable consumption, body mass index, and diabetes 
prevalence as a function of demographic and behavioral characteristics, and linked these 
models with population microdata developed using spatial microsimulation to 
characterize high-risk populations and locations. Individuals with lower income and 
educational attainment had lower rates of multiple health-promoting behaviors (e.g., fruit 
and vegetable consumption and exercise) and higher rates of self-reported diabetes. Our 
models in combination with the simulated population microdata identified census tracts 
with an elevated percentage of high-risk subpopulations, information community partners 
can use to prioritize funding and intervention programs. Multi-stressor modeling using 
data from public databases and microsimulation methods for characterizing high-
resolution spatial patterns of population attributes, coupled with strong community 
partner engagement, can provide significant insight for intervention. Our methodology is 







There is a need to characterize patterns of risk factors within communities at a 
resolution that is meaningful to community-level public health efforts. Geographic 
information systems (GIS) have become a popular and powerful tool in community 
health96, especially when publicly available databases have been leveraged. Public health 
and population health studies have been undertaken to address this need, including 
through the development of various spatial microsimulation methodologies in the US, 
UK, New Zealand and Australia on topics such as poverty, obesity, smoking, and mental 
health.78–82 In this context, we define spatial microsimulation as the use of simulation 
methods to generate individual-level data at higher geographic resolution than available 
in publicly available administrative datasets. While these studies provided important 
insights at a high geographic resolution, these spatial microsimulation methods have not 
typically been developed or applied to respond directly to community members’ or 
community-serving organizations’ needs.    
Developing meaningful models within a community context requires a shift from 
conducting research on communities to working collaboratively on topics of mutual 
interest.97 Zip code level community-engaged plans were developed in Florida to address 
infant mortality98 and in Michigan99 to tackle diabetes prevalence. While these studies 
provided important insights relevant to public health policy and practice, the low 
geographic resolution make the data less nuanced than studies utilizing spatial 
microsimulation techniques. When attempting to determine optimal intervention 




are required, but studies have not previously generated this information following a 
process that would most meaningfully inform community decision-making.  
In this study, we focused on New Bedford, Massachusetts (MA), USA, a low-
income city with multiple environmental and public health challenges. Given limited 
resources and a diverse population, within-city comparisons are crucial to local 
government and community-based organizational needs assessments and planning. We 
leveraged our previously developed spatial microsimulation methodology to predict high-
resolution patterns of multiple risk factors by: 1) constructing a simulated population with 
multivariable demographic attributes at high spatial resolution (synthetic microdata), and 
2) building regression models using public databases to predict risk factors of concern to 
community partners as a function of available demographic information.77,100 To our 
knowledge, this is the first application that has directly connected spatial microsimulation 




New Bedford is a city located in southeastern MA, with a population of 
approximately 95,000 according to the 2010 US Census. 17% are Hispanic/Latino (10% 
statewide), 43% live in owner-occupied housing (62% statewide), 37% speak a language 
other than English at home (22% statewide), 30% are less than high school educated 
(10% statewide), 13% are living with a disability (8% statewide) and 24% live in poverty 




groups meeting one of the MA environmental justice (EJ) criteria (i.e., low median 
household income, high percentage of minority or limited English proficiency).103  
Construct New Bedford synthetic microdata 
Our spatial microsimulation methodology for constructing the synthetic microdata 
has been published previously.77 Briefly, the synthetic microdata were developed by 
combining individual-level microdata with coarse geographic resolution (Public Use 
Microdata Area) with census tract-level constraints from the American Community 
Survey (ACS), applying probabilistic reweighting using simulated annealing to optimize 
the assignment of individuals to census tracts. New Bedford includes 31 census tracts, 
with a mean population of 3,063 (range: 1,448 – 5,591). The census tract-level 
constraints included 8 individual-level constraints (ancestry, sex, age, educational 
attainment, sex by age, sex by educational attainment, age by educational attainment, and 
sex by age by educational attainment) and 5 household-level constraints (head of 
household age, household income, rent/own, rent/own by head of household age, 
household income by head of household age). This resulted in a database of 94,944 
individuals representing New Bedford residents, populated with individual 
sociodemographic and housing characteristics at a census tract resolution.  
Prioritize health outcomes and risk factors  
Community partner organizations on the team included a non-profit organization, 
NorthStar Learning Centers, with the mission to assist and empower youth to overcome 
adversity resulting from poverty, educational disadvantage, and other stressors so they 




the Office of Environmental Stewardship, which directs the City’s environmental 
compliance and planning efforts. The university and community partners first began 
working together in 2010, as collaborators on an EPA STAR grant on the topic of 
incorporating nonchemical stressors into cumulative risk assessment. The collaboration 
was initiated given mutual interest in attention deficit hyperactivity disorder and its 
impact on schools and children. Throughout that grant, we held monthly team meetings 
and community partners provided regular input to study design and implementation, 
including extensive survey data collection. At the end of the funding period, we formally 
reflected on our model for community engagement104 and concluded that while we had 
developed a strong partnership and expanded the scope of topics of interest to the 
community partners, there was a need to conduct action-oriented work led by community 
partner interests subsequent to the end of the grant.  
The research team discussed the possibility of leveraging the synthetic microdata 
to address high-priority needs defined by the community partners. Subsequent to some 
brainstorming conversations, we determined that the most relevant database given the 
domains of community interest would be the Behavioral Risk Factor Surveillance System 
(BRFSS), a national telephone survey of adults ages 18 and older used to collect 
information yearly on a wide range of health risk behaviors and health conditions.105 We 
then developed a formal collaborative process to select outcomes from the BRFSS. The 
university partners generated information on all relevant questions from the BRFSS, and 
we held multiple meetings to determine the subset of questions of greatest interest. 




partners, modifiable behaviors or interventions, and potential for funding to implement 
interventions. The 3 behaviors/outcomes selected included exercise, fruit and vegetable 
consumption, and diabetes. We also modeled self-reported body mass index (BMI) given 
a strong association with diabetes and other outcomes.   
Literature search for candidate predictors 
We conducted a literature search in September 2015 to identify predictors of 
exercise, fruit and vegetable consumption, BMI, and diabetes. We conducted searches in 
Google Scholar, PubMed, and Web of Science, using search terms such as the 4 health 
outcomes/behaviors and “predictor” or “risk factor” to identify articles of interest. A list 
of candidate variables was compiled from these articles, and we selected the subset that 
were available both in the BRFSS and the New Bedford synthetic microdata.  
Regression modeling  
All regression models were built using data from the 2005-2010 MA BRFSS, a 
database of individual observations that includes variables on health risk behaviors, 
health conditions, and demographics. We built regression models from Bristol County 
data (n=15,814), which is inclusive of New Bedford (the largest city in Bristol County). 
We modeled the 3 primary behaviors/outcomes of interest by building multivariable 
logistic regression models from questions in the BRFSS, for exercise (did you do any 
exercise in the past 30 days?), fruit and vegetable consumption (do you eat 5 more 
servings of fruit or vegetable a day?) and diabetes prevalence (have you ever been told by 
a doctor that you have diabetes?). We also built a multivariable linear regression of BMI 




and covariates were based on the structure within the BRFSS, with categories collapsed 
for a subset of questions (e.g., income) with sparse data in some categorical responses. 
Models were constructed by backward selection using SAS statistical software version 
9.4 (SAS Institute Inc., Cary, NC). The criterion for dropping a variable was a p-value of 
greater than 0.05. We tested the sensitivity of our findings by applying the same model to 
BRFSS data restricted to New Bedford only (n=4,399). 
Outcome prediction 
We predicted probabilities of any exercise in the past 30 days, of eating 5 or more 
servings of fruits or vegetables daily, of BMI categories (continuous BMI was predicted 
and then categorized), and of diabetes status for each individual in the synthetic 
microdata by applying the multivariable regression models to the synthetic population. 
The synthetic population includes individual-level demographic variables (e.g., age, 
gender, race/ethnicity, education, income) as well as predicted variables for smoking and 
alcohol use, at census tract resolution.77 The BRFSS collects information from 
individuals 18 and older, however our study synthetic population was restricted to 
include only individuals who could legally consume alcohol, thus age 21 and older.  
To quantify uncertainty for each of the binary outcomes for which probabilities 
were assigned, a Monte Carlo simulation was run using @Risk version 7 (Palisade 
Corporation, Ithaca NY) (uncertainty was not quantified for BMI). Each model was 
simulated 1,000 times, and individual coefficients of variation around each predicted 
binary outcome at the census tract level were calculated. To evaluate the internal 




measures reported by the Massachusetts Department of Public Health (MA DPH) for 
BRFSS data from 2005-2010 for New Bedford.  
Outcome presentation  
Predicted individual exercise, fruit and vegetable consumption and diabetes status 
were aggregated by census tract and mapped using ArcMap 10.1 (Esri, Redlands, CA). 
Maps as well as data tables were refined with community partners to maximize 
applicability to community needs. For example, community partners provided feedback 
on map aesthetics and on questions for which maps would be more or less valuable than 
tabular presentations of key statistics. Refined versions of the maps along with supporting 
tables were then presented to other interested community stakeholders. 
Results 
Literature search results 
We reviewed 45 publications from the literature to identify established predictors 
of exercise, fruit and vegetable consumption, BMI, and diabetes (publications are listed 
in the bibliography in the supplemental material). Candidate predictors are listed in 
supplemental Table S2.1 and indicate those variables found in the literature that were also 
available in the BRFSS and the New Bedford synthetic microdata. Predictors selected to 
build the regression models were sex, age, race/ethnicity, income, education, 
employment, smoking status, alcohol consumption, exercise, diet and BMI. 
Regression model results 
Our regression model for probability of exercising in the past 30 days, based on 




Hispanic, lower income, less educated, a current smoker, or not having at least one 
alcoholic drink in the past 30 days were associated with being less likely to have partaken 
in any exercise in the past 30 days (Table 2.1). Being male, less educated, a current 
smoker, or not exercising in the past 30 days were associated with being less likely to eat 
5 or more servings of fruits or vegetables daily (Table 2.1). Being male, lower income, 
less educated, not having at least one alcoholic drink the past 30 days, not exercising in 
the past 30 days, or not consuming 5 or more serving of fruits or vegetables daily were 
associated with a higher BMI (Table 2.1). Lastly, adults who were male, older, low 
income, a former smoker, did not have at least one alcoholic drink in the past 30 days, did 
not exercise during the past 30 days, or were obese were more likely to have been told by 
a health professional that they had diabetes (Table 2.1). Findings were similar when 
regression models were built from BRFSS data restricted to observations from New 
Bedford (base population n=4,399) (Table S2.2). 
The multivariable regression models reveal which groups of adults are at high risk 
for the multiple risk factors explored. For example, lower income individuals were less 
likely to exercise and were more likely to have a higher BMI and have diabetes. Less 
educated individuals were less likely to exercise or eat 5 or more servings of fruits or 
vegetables, and were more likely to have a higher BMI. Patterns were more complex for 
some subpopulations. While men were less likely to consume 5 or more servings of fruits 
and vegetables, women were less likely to exercise. Current smokers were less likely to 
exercise and consume 5 or more servings of fruits and vegetables, but had a lower BMI 




the highest-risk population for diabetes. Importantly, these predictors do not necessarily 
reflect causal pathways, but rather represent clusters of behaviors and demographic 
characteristics that are often found together — in other words, smoking is not protective 
against diabetes, but diabetics are less likely to be current smokers given medical 
recommendations and potential adaptive behaviors.  
Identification of census tracts with populations at high risk for modeled outcomes 
The regression models were applied to the synthetic microdata, and the resulting 
patterns by census tract were mapped for exercise, fruit and vegetable consumption, and 
diabetes prevalence (Figure 2.1). We examined overall spatial patterns with specific 
emphasis on 4 census tracts of a priori interest to community partners. These census 
tracts were entirely compromised of census tract block groups that met one or more of the 
MA EJ criteria (i.e., low median household income, high percentage of minority, or 
limited English proficiency)103, and they were of particular interest for ongoing 
Brownfields Area Wide Planning efforts and an upcoming brownfields grant submission 
by the community partners. Exercise prevalence was lowest in eastern central and 
southeast New Bedford (Figure 2.1a). Similar patterns were seen for fruit and vegetable 
consumption; farmers markets were located in census tracts with relatively higher 
consumption rates (Figure 2.1b). Unlike exercise and fruit and vegetable consumption 
prevalence, census tracts with the highest diabetes prevalence were not concentrated 
within one area of New Bedford, consistent with the importance of age as a predictor 
(Figure 2.1c). Exercise and fruit and vegetable consumption rates for all 4 census tracts of 




generally lower than the city average, consistent with the younger and more female 
populations in those tracts.  
Evaluation of results 
The proportion of people who exercise, consume 5 or more servings of fruits and 
vegetables and have diabetes were computed for our synthetic population and compared 
to proportion data reported by the MA DPH106, and in all three cases the 95% confidence 
intervals overlapped (Table 2.2). The corresponding values for the state of Massachusetts 
reinforce the greater risk of poor health in New Bedford than statewide. A higher 
percentage of the population in Massachusetts exercises and eats 5 or more servings of 
fruits and vegetables compared to the population in New Bedford, and diabetes 
prevalence is lower statewide. 
Discussion 
As expected, significant predictors in our models matched those found in the 
literature. For example, Boutelle et al. (2004) found that exercise was associated with 
ethnicity, income and smoking.107 Trudeau et al. (2003) found that differences existed 
between predictors of fruit and vegetable consumption by gender, and predictors included 
age, education, exercise and smoking.108 In the literature, employment109 as well as 
income and education were found to be significant predictors of BMI.110 Lastly, 
predictors of diabetes included demographics, BMI, diet and lifestyle indicators.111 In 
spite of the number of highly significant predictors, only a small fraction of variability in 
these behaviors and outcomes can be explained by basic sociodemographic predictors. 




support, attitudes and environmental factors112,113, and a systematic review of the 
literature on fruit and vegetable consumption found that the majority of the literature 
examines predictors including intentions, attitudes, perceived barriers and autonomy114, 
which are more specific predictors not readily available in publicly available datasets. 
That said, our ability to determine sociodemographic predictors of key behaviors and 
outcomes allowed us to connect with a population dataset developed through spatial 
microsimulation, thereby yielding predictions of within-city variability not otherwise 
available. 
In conversations between university and community partners, community partners 
indicated value in determining factors that show the needs of specific New Bedford 
census tracts in comparison to elsewhere in New Bedford, the rest of Massachusetts, or 
the nation. The results can be used to help target planning efforts on and within particular 
neighborhoods. Specifically, annual applications for brownfield grants to further the 
city’s EJ efforts are augmented by providing data-driven demographically and spatially 
resolved insights in their applications. Similarly, grant applications to expand the farmers 
market program are greatly informed by spatially resolved insight about high-risk 
subpopulations. The modeled data provide needed information to focus health promotion 
efforts at a geographically resolved level that was not previously or publicly available to 
government agencies, non-profits or community groups. The novelty of this application is 
most markedly apparent in Figure 2.1, which conveys variability in need across New 
Bedford, along with the marked differences with the state as a whole (Table 2.2). 




groups that could be targeted, either independent from or in conjunction with spatially-
oriented interventions. For example, lower income individuals with lower educational 
attainment in New Bedford had lower rates of multiple health-promoting behaviors and 
higher rates of diabetes. 
The spatial microsimulation and linked regression modeling methodology used in 
New Bedford can be applied to any community across the US, given that we relied on 
public databases available for any location, and could generalize to other countries given 
analogous census data and representative population surveys. While needs vary across 
communities, data-driven insights about geographic and demographic patterns of 
modifiable health behaviors within communities can be used to create or enhance current 
community programming and interventions, obtain funding for interventions, or to 
support policy and advocacy efforts.  
While the analytic methods in our study are generalizable and have demonstrated 
utility in the public health literature, another key dimension of our project involved strong 
community partner engagement, which allowed us to design and implement statistical 
models that could directly inform community-scale public health programs. This type of 
engaged research involves a shift from research on communities (one-way) to bi-
directional community engagement in which researchers share power and conduct studies 
with communities.97 The benefits of bi-directional community engagement are clear: the 
researchers develop a better understanding, communication with, and connection to the 
community, and the community benefits from the research, tools, and technical expertise, 




challenges, including initiating, maintaining and developing a relationship with a 
community that includes diverse stakeholders, and balancing competing priorities and 
expectations116, community-engaged research ultimately leads to improved research 
quality, community relevant research, and impactful research that addresses health 
disparities.117 The demonstrated tools and data can lead to more targeted programming, 
better allocation of resources, enhanced community decision-making, and overall 
improved health of communities.  
One limitation of the study is the number of predictors available for the regression 
models, shown in Table S2.1. We were constrained to using only variables available in 
the synthetic population, which was derived from ACS, and does not capture specific 
behaviors that contribute to the risk of behaviors and outcomes. There are subpopulations 
that this methodology does not fully capture, including certain immigrant groups and 
some English language learners. In 2015, community organizations estimated 
undocumented immigrants to number 10,000 in New Bedford.118 Information from these 
subpopulations will not be represented in administrative databases and may have distinct 
behavioral patterns, as newly arrived immigrants often reflect the health behaviors and 
outcomes of their home country, also known as the “healthy immigrant effect”.119 
Because BRFSS is a phone survey conducted in English, barriers to participation are 
access to a phone and English language proficiency. Children are also not captured 
because there is a lack of information on those less than 18 years old in administrative 
datasets despite the high interest and need for such databases. 




outside of New Bedford. While using the models created from the New Bedford data 
only would be a more accurate representation of New Bedford given potential differences 
in demographic patterns in other communities in Bristol County, the smaller sample size 
would contribute to greater statistical uncertainty. We tested our models with both 
datasets and found very similar results (Table S2.2). Many communities interested in this 
method may have much smaller populations, and the insights our models provided for 
community-level decision-making were robust to this choice, but this issue should be 
considered carefully when developing models in other locations, as demographic 
predictors may or may not generalize. 
Our spatial microsimulation methods provide key data to inform decisions, but 
even setting aside the limited set of available predictors, they do not address the 
complexity of community issues that contribute to exercise, fruit or vegetable 
consumption, and diabetes rates. For example, identifying census tracts with low fruit and 
vegetable consumption to inform community action (such as adding a farmers’ market) 
may not lead to increased fruit and vegetable consumption. Improvement of diets is 
multi-faceted and complex—the produce being sold needs to be culturally relevant, 
affordable, and accessible.120 Lastly, a limitation of the maps as a community information 
tool is that the maps may be misinterpreted by residents because the patterns in outcomes 
are related to sociodemographic risk factor patterns and not necessarily to the geography 
of where they live. 
Nonetheless, our modeling approach adds value relative to the literature by 




communities with decision-making using publicly available data, which tends to be more 
basic rather than nuanced. Therefore, our locally-informed models enable researchers to 
generate data from public databases for communities in a cost-effective, less resource 
intensive and realistic manner, which could be followed up with more extensive surveys 
or local data collection if needed. 
Conclusions 
We conducted a community partner engaged analysis in the city of New Bedford, 
identifying health outcomes and behaviors of interest, developing spatial microsimulation 
models to characterize demographic and geographic patterns of those outcomes and 
behaviors, and sharing the results to inform community partner decision-making and 
resource allocation or attainment. The combination of complex simulation modeling, 
strong community partner engagement, and use of public administrative databases is a 
significant strength of this study and one that can generalize to other settings and 
situations where public health priorities are being determined. While the university and 
community partners in this study had a working relationship that predated this analysis, 
the relationships and mutual understanding matured through the collaborative process. 
The community partners broadened their scope of work and field of vision of community 
health and environmental planning, while the university partners’ understanding and 
appreciation of the needs and strengths of the community were deepened, which will 
allow future research in the city to be tailored to meet those needs. Our model platform 
can be expanded to address other variables of interest within New Bedford or to include 









Table 2.1 Multivariable regression coefficients for exercise, fruit and vegetable 
consumption, body mass index (BMI), and diabetes constructed from Behavioral Risk 
Factor Surveillance System (BRFSS) data for Bristol County, Massachusetts (2005–
2010). 
 Main effect coefficients for each modeled outcome 
Covariate Exercise Fruit/ vegetablea 
BMIb Diabetesc 
Sex 
     Male 0.086* -0.29* 0.036* 0.21* 
Age  
     18-29 0.40* -0.14 0.047* -1.65* 
     30-39 0.18* -0.35* 0.093* -0.93* 
     40-49 0.072 -0.13 0.094* -0.29* 
     50-59 -0.040 0.052 0.11* 0.44* 
     60-69 -0.077 0.062 0.11* 0.72* 
     70-79 -0.12* 0.16 0.079* 0.99* 
Race/ethnicity 
     Black, non-Hispanic -0.021 0.21 NS 0.071 
     Hispanic -0.35* 0.20 NS 0.19 
     Other (includes Asian) 0.24* -0.19 NS -0.11 
Income  
     < 25k -0.20* 0.051 0.02* 0.27* 
     25,000-34,999 -0.014 -0.17* 0.0098 -0.068 
Education  
     < HS -0.26* -0.18* 0.034* NS 
     HS -0.077* 0.000039 0.022* NS 
Smoking  
     Current -0.30* -0.30* -0.05* -0.057* 
     Former 0.096* 0.078 0.0076 0.17* 
Alcohol  
     At least 1 drink in past 30 days 0.25* NS -0.030* -0.36* 
Exercise 
     Any exercise in past 30 days N/A 0.33* -0.043* -0.083* 
Fruit/vegetable consumption 
     5 or more servings daily N/A N/A -0.019* NS 
BMI category 
     Obese (BMI >=30) N/A N/A N/A 0.91* 
     Overweight (30>BMI >= 25) N/A N/A N/A 0.054 
     Normal Weight (18.5<= BMI <25) N/A N/A N/A -0.53* 
Notes: BMI model is a linear regression, and other models are logistic regressions. Full models with 
standard errors are in Table S2.2. a Exercise: self-reported any exercise in the past 30 days, b 
Fruit/vegetable: self-reported 5 or more servings of fruit and vegetables daily, c Diabetes: self-reported ever 
being told they have diabetes by a doctor; Reference groups: female, age 80–99, White Non-Hispanic, 
income $35,000 and over, above high school education, never smoked, no alcohol in past 30 days, no 
exercise in past 30 days, < 5 servings of fruits/vegetables daily, underweight (BMI < 18.5); * significant at 
p < 0.05; NS: not a significant predictor, p-value ≥ 0.05, predictor dropped from the final model; N/A: not 




Table 2.2 Comparison of mean prevalence of exercising, fruit and vegetable 
consumption, and diabetes estimated from synthetic microdata compared to New Bedford 
and Massachusetts 2005–2010 BRFSS estimates for adults 21 years and older. 
















the past 30 days) 




(≥ 5 daily) 




11.1 (9.8 – 12.4)% 10.3 (9.3 – 11.4)% 7.4 (7.2 – 7.6)% 
* Source: MA DPH, 2016. Note on MA DPH, 2016 data: estimates for New Bedford 









Figure 2.1 (a) Predicted exercise, (b) fruit and vegetable consumption and (c) diabetes prevalence by census tract in New 
Bedford, MA estimated using synthetic population microdata.  
 
Black outlined census tracts were identified as high priority by community partners. Coefficients of variation around each 
predicted outcome at the census tract level were calculated by running a Monte Carlo simulation of each model 1000 times to 
quantify uncertainty. Data sources: exercise, fruit/vegetable and diabetes proportions modeled from MA BRFSS 2005-2010 






Table S2.1 Candidate predictors of exercise, fruit and vegetable consumption, BMI and 
diabetes from the literature compared to the predictors available in the BRFSS and 
synthetic microdata. 
Predictors 
Selected predictors identified from 
literature review Predictors 




























l  Sex X X X X X 
Age X X X X X 
Race/ethnicity X X X X X 
Income X X X X X 
Education X X X X X 
Employment X X X  X 
Smoking X X X X X 
Alcohol  X  X X X 
Exercise  X X X X 
Diet   X X X 
BMI X X  X X 
Social support X X    
Self-efficacy X X    
Marital status X X    







Sleep X  X   
Mental health X  X   
Hypertension    X  
Hypocholesteremia    X  
Food Access  X X   
Screen time 





Green space X  X   








Table S2.2 Comparison of multivariable regressions coefficients predicting (a) any 
exercise in the past 30 days, (b) daily fruit and vegetable consumption, (c) BMI and (d) 
diabetes constructed from BRFSS data for Bristol County, MA (2005-2010) and New 
Bedford, MA 
(a)  
  Bristol County Model New Bedford Model   







Intercept 0.60 0.047 <.0001 0.62 0.067 <.0001 
Sex  
     Male 0.086 0.021 <.0001 0.11 0.040 0.0062 
Age  
     18-29 0.40 0.070 <.0001 0.34 0.12 0.0035 
     30-39 0.18 0.053 0.0005 0.29 0.096 0.0026 
     40-49 0.072 0.047 0.12 0.083 0.086 0.34 
     50-59 -0.040 0.043 0.35 -0.035 0.079 0.66 
     60-69 -0.077 0.045 0.087 -0.032 0.086 0.71 
     70-79 -0.12 0.053 0.020 -0.23 0.10 0.024 
Race/ethnicity  
     Black, non-
Hispanic 
-0.021 0.096 0.83 0.051 0.12 0.68 
     Hispanic -0.35 0.072 <.0001 -0.40 0.10 <.0001 
     Other (includes 
Asian) 
0.24 0.083 0.0033 0.26 0.12 0.023 
Income  
     < 25k -0.20 0.032 <.0001 -0.23 0.060 <.0001 
     25,000-34,999 -0.014 0.040 0.72 -0.0035 0.073 0.96 
Education  
     < HS -0.26 0.036 <.0001 -0.24 0.062 0.0001 
     HS -0.077 0.030 0.0075 -0.041 0.053 0.44 
Smoking  
     Current -0.30 0.032 <.0001 -0.27 0.058 <.0001 
     Former 0.096 0.030 0.0015 0.081 0.059 0.17 
Alcohol  
 At least 1 drink 
in past 30 days 0.25 0.021 <.0001 0.22 0.040 <.0001 
Bristol PROC LOGISTIC: exercise = sex + age + race + income + education + smoking + 
alcohol 
New Bedford PROC LOGISTIC: exercise = sex + age + race + income + education + smoking 
+alcohol 
Reference: female, age 80-99, White Non-Hispanic, 35k and over, above high school education, 




















Intercept -1.5 0.079 <.0001 -1.5 0.12 <.0001 
Sex  
     Male -0.29 0.033 <.0001 -0.16 0.065 0.016 
Age  
     18-29 -0.14 0.10 0.17 -0.22  0.18  0.23  
     30-39 -0.35 0.083 <.0001  -0.18  0.15 0.24  
     40-49 -0.13 0.073 0.069  -0.049 0.14  0.72  
     50-59 0.052 0.065 0.43  0.040  0.13 0.75  
     60-69 0.062 0.071 0.38  -0.12  0.15 0.43  
     70-79 0.16 0.083 0.057  0.041  0.16 0.80  
Race/ethnicity 
     Black, non-
Hispanic 0.21 0.14 0.15  0.40 0.19  0.031  
     Hispanic 0.20 0.12 0.10  -0.04 0.18  0.84  
     Other (includes 
Asian) -0.19 0.14 0.17  -0.26 0.20  0.20  
Income  
     < 25k 0.051 0.055 0.36  0.14 0.010  0.16  
     25,000-34,999 -0.17 0.067 0.012  -0.11 0.13  0.37 
Education  
     < HS -0.18 0.067 0.0062 -0.11  0.11  0.32  
     HS 0.000039 0.050 0.99  -0.090 0.092  0.33  
Smoking  
     Current -0.30 0.058 <.0001 -0.28 0.11 0.0076 
     Former 0.078 0.049 0.11 0.031 0.096 0.75 
Exercise   
 Any exercise in 
past  30 days 0.33   0.039 <.0001 0.28 0.071 <.0001 
Bristol PROC LOGISTIC: fruit and vegetable consumption = sex + age + race + 
income + education + smoking + exercise 
New Bedford PROC LOGISTIC: fruit and vegetable consumption= sex + smoking + 
exercise 
Reference: female, age 80-99, White Non-Hispanic, 35k and over, above high school 











  Bristol County Model New Bedford Model 
Covariate Beta Standard 
Error 




Intercept 7.8 0.011 <.0001 7.9 0.022 <.0001 
Sex  
     Male 0.036 0.0048 <.0001  0.009
5 
0.0096  0.33 
Age  
     18-29 0.047 0.012 <.0001 0.045 0.023 0.049 
     30-39 0.093 0.011 <.0001 0.092 0.022 <.0001 
     40-49 0.094 0.011 <.0001 0.086 0.021 <.0001 
     50-59 0.11 0.010 <.0001 0.12 0.020 <.0001 
     60-69 0.11 0.010 <.0001 0.10 0.021 <.0001 
     70-79 0.079 0.011 <.0001 0.065 0.022 0.0026 
Income  
     < 25k 0.021 0.0061 0.0005  0.017 0.011 0.13 
     25,000-34,999 0.010 0.0076 0.20  0.0049 0.015  0.74  
Education  
     < HS 0.034 0.0074 <.0001 0.023 0.013 0.095 
     HS 0.022 0.0055 <.0001 0.017 0.011 0.11 
Smoking  
     Current -0.051 0.0062 <.0001 -0.059 0.012 <.0001 
     Former 0.0076 0.0055 0.17 0.010 0.011 0.37 
Alcohol  
     At least 1 drink 
in past 30 days -0.030 0.0050 <.0001 -0.032 0.0098 0.0012 
Exercise  
     Any exercise in 
past 30 days 
-0.043  0.0053 <.0001 -0.048 0.010 <.0001 
Fruit and vegetable consumption  
     5 or more 
servings of fruit 
daily 
-0.020  0.0055  0.0007 -0.019 0.011 0.079 
Bristol PROC GLM: Log(BMI) = sex + age + income + education + smoking + alcohol + 
exercise + fruit and vegetable consumption 
New Bedford PROC GLM: Log(BMI)=age + education + employment + smoking + alcohol + 
exercise + fruit and vegetable consumption 
Reference: female, age 80-99, 35k and over, above high school education, unemployed, never 








  Bristol County Model New Bedford Model 








Intercept -2.4 0.11 <.0001 -2.4 0.19 <.0001 
Sex  
     Male 0.21 0.031 <.0001 0.14 0.057 0.017 
Age 
     18-29 -1.65 0.22 <.0001 -1.4 0.30 <.0001 
     30-39 -0.93 0.12 <.0001 -0.99 0.20 <.0001 
     40-49 -0.29 0.087 0.0007 -0.25 0.15 0.08 
     50-59 0.44 0.068 <.0001 0.53 0.11 <.0001 
     60-69 0.72 0.067 <.0001 0.47 0.12 <.0001 
     70-79 0.99 0.074 <.0001 0.85 0.13 <.0001 
Race/ethnicity  
     Black, non-
Hispanic 0.071 0.14 0.62  0.17  0.18 0.36  
     Hispanic 0.19 0.11 0.074  0.22 0.15  0.14  
     Other (includes 
Asian) -0.11 0.12 0.37  -0.30 0.17  0.09  
Income  
     < 25k 0.27 0.044 <.0001 0.30 0.081 0.0002 
     25,000-34,999 -0.068 0.058 0.24 -0.11 0.11 0.33 
Smoking  
     Current -0.057 0.051 <.0001 -0.15 0.091 0.09 
     Former 0.17 0.042 <.0001 0.30 0.078 0.0001 
Alcohol   
 At least 1 drink in 
past 30 days -0.36 0.032 <.0001 -0.40 0.060 <.0001 
Exercise  
     Any exercise in 
past 30 days -0.083 0.031 0.0069  -0.0011 0.056  0.98  
BMI category  
     Obese (BMI 
>=30) 
0.91 0.090 <.0001 0.89 0.17 <.0001 
     Overweight 




-0.53 0.097 <.0001 -0.46 0.18 0.013 
Bristol PROC LOGISTIC: diabetes = sex + age + race + income + smoking + alcohol + 
exercise + BMI category 
New Bedford PROC LOGISTIC: diabetes= sex + age + income + smoking + BMI category 
Reference: female, age 80-99, White Non-Hispanic, 35k and over, never smoked, no alcoholic 
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Background: Extensive data available in electronic health records (EHR) have the 
potential to improve asthma care and understanding of factors influencing asthma 
outcomes. However, this work can only be accomplished when the EHR data allow for 
accurate measures of severity, which at present are complex and inconsistent.  
Objective: To create and evaluate a standardized pediatric asthma severity phenotype 
based in clinical asthma guidelines for use in EHR-based health initiatives and studies; 
and to examine the presence and absence of these data in relation to patient 
characteristics. 
Methods: We developed an asthma severity computable phenotype and compared the 
concordance of different severity components contributing to the phenotype to trends in 
the literature. We used multivariable logistic regression to assess the presence of EHR 
data relevant to asthma severity.   
Results:  The asthma severity computable phenotype performs as expected in 
comparison to national statistics and the literature. Severity classification for a child is 
maximized when based on the long-term medication regimen component and minimized 
when based only on the symptom data component. Use of the severity phenotype results 
in better, clinically-grounded classification. Children for whom severity could be 
ascertained from these EHR data were more likely to be seen for asthma in the outpatient 
setting, and less likely to be older or Hispanic. Black children were less likely to have 





Conclusion: We developed a pragmatic computable phenotype for pediatric asthma 
severity that is transportable to other EHRs.  
Clinical Implication: Ascertainment of asthma severity from the EHR is viable but 
depends on intensity of patient engagement in healthcare and demographic 







 Electronic health records (EHRs) are potentially rich “big data” sources of 
detailed longitudinal health information. EHRs are increasingly used for research to 
advance therapeutics, improve patient care, and epidemiology.11,12,33 Despite the potential 
opportunities EHR data present to conduct large-scale studies in a timely fashion and at a 
lower cost than traditional studies, there are significant challenges in their application in 
research, such as data quality (incomplete, incorrect, and discordant)36, standardization38, 
and interoperability.121  
 The data in the EHR may not reflect the underlying disease that researchers are 
interested in studying, but rather the totality of complex patient, clinician, and health 
system interactions and documentation (or lack thereof.)48 Data in EHRs represent 
complex visit and documentation processes—a concept that has been termed informed 
presence.43 Thus to study a disease of interest, researchers must understand the 
idiosyncrasies of the healthcare process that give rise to the data documented in the 
EHR.48 Idiosyncrasies such as the effect of the weekend on hospital admissions122 or 
treatment options sought by patients varying by distance from healthcare facilities123 may 
or may not be relevant to the disease and the EHR data a researcher is analyzing. A 
researcher must first understand the potential biases that result from informed presence, 
and only then can such biases be addressed42 or creatively exploited54,124 using 
approaches only recently described in the epidemiological and informatics literature. 
Characterizing and defining asthma severity and its components has varied in the 





Idiosyncrasies of asthma EHR data relevant to severity include: lung function testing is 
often performed on severe patients; the frequency of interactions with the health care 
system varies by severity; and assessment may be clinically subjective given the diffuse 
clinical definition of severity. In spite of these complexities of standardized ascertainment 
of asthma severity status from EHR data, it is important to tackle because asthma severity 
is: 1) integral to an asthma diagnosis and treatment plan in the clinical setting; 2) a key 
element of valid and interpretable  research; 3) highly associated with significant 
economic burden nationally and internationally83–85; 4) relevant to advancing risk 
prediction of asthma morbidity and mortality.86–89 
To date, relatively few research studies using sophisticated methodologies130–132 
applied to “big data” have been translated into clinical practice with documented 
improvement in asthma care.44,133 Limitations of EHR data36,40,134 can be mitigated 
through interdisciplinary collaboration.44 Thus, an aim of our research was to integrate 
the knowledge and skill base of a team of clinicians, informaticians, and health scientists 
to advance pediatric asthma research using EHR data, with the goal of developing a 
computable phenotype. A computable phenotype is “a clinical condition or characteristic 
that can be ascertained via a computerized query to an EHR system or clinical data 
repository using a defined set of data elements and logical expressions so as to be able to 
identify patients from clinical data for research purposes”.45,46 Computable phenotyping 
is therefore the process used to identify and understand the actual patient population in 
the EHR sample under study.39,135 A goal of phenotyping is to leverage clinical and 





systems, thus supporting the scale-up of “big data” health research.47   
The objectives of this study are to create a standardized pediatric asthma severity 
phenotype that is based in clinical asthma guidelines and to evaluate documentation of 
visit processes and patient characteristics that give rise to the presence of these data in the 
EHR. The following two research questions were posed for our second objective: what 
data are observed for those patients for whom we can ascertain an asthma severity 
classification compared to those patients for whom we cannot? And among those with 
severity data, why do some patients have different data elements related to asthma 
severity components while others do not (e.g., lung function test, recorded asthma 
symptoms)?53 This study extends the current science of mainly binary phenotypes (e.g., 
asthmatic versus non-asthmatic)136 by creating a multi-class computable phenotype for 
asthma severity. While an asthma computable phenotype exists in the literature90,91, to 
our knowledge, no validated and standardized computable phenotype that is based on 
clinical asthma guidelines exists for asthma severity.92,93  
Methods 
The Boston University Medical Campus Institutional Review Board approved The 
Asthma Simulation Tool for Housing, Medication, and Social Adversity (ASTHMA) 
Study in May 2018. Figure 1 provides a high-level summary of our study design and 
analyses. 
Severity phenotype development  
Interdisciplinary team: The asthma severity phenotype presented in Table 3.1 was 





informaticians, and health scientists using best practices for phenotype development from 
the National Institutes of Health (NIH).45  
Basis of asthma severity phenotype definition: Our phenotype is based on clinical 
guidelines established in the National Heart, Lung, and Blood Institute (NHLBI) 2007 
National Asthma Education and Prevention Program Expert Panel Report 3 (NAEPP 
EPR3)137 and supplemented with the 2019 Global Initiative for Asthma (GINA) 
Report.138 The Classifying Asthma Severity Table139 outlined in the NAEPP EPR3 
reflects the culmination of significant clinical iteration and expertise and is ideally 
summarized for translation into an informatics approach (Table 3.1). Thus, the NAEPP 
EPR3 was considered preferential to other approaches (Healthcare Effectiveness Data 
and Information Set (HEDIS) or the Leidy method.)92,93 
Pragmatic approach for replication: We applied a set of principles when building the 
severity phenotype: to build upon existing phenotypes, ground the phenotype in clinical 
guidelines, and develop a transportable phenotype.45 The phenotype was built on 
ontologies based on standard national reference codes.140 The time-scale of the phenotype 
is one calendar year and the phenotype indicates the worst severity observed based on 
any of the EHR data elements in the given year. This logic was based on the NAEPP 
EPR3 severity guidelines, the clinical expertise of the team and literature, and for 
comparability to the time-scale of claims-based asthma severity algorithms.92,93,129 
EHR database & asthma phenotype: We constructed a database of children (ages 0 to 
18) seen at Boston Medical Center (BMC) from 2003 onward (CHILD-DB) as an aim of 





safety net hospital in New England and primarily serves a low-income and minority 
population. CHILD-DB is a limited dataset that includes individual child attributes from 
the EHR as well as geospatial data (e.g., air pollution, census data.) Children in CHILD-
DB were first classified as having asthma by applying criteria from a published asthma 
computable phenotype91 that was iteratively developed and validated in adults, children 
(ages 5 and older), and across health institutions.90,91 Because the asthma phenotype was 
created with ICD-9 codes, we updated it to include corresponding exclusionary ICD-10 
codes (Table S3.1.) 
Asthma severity phenotype: We defined severity (detailed in Table 3.1) on an annual 
basis (calendar year) according to the NAEPP EPR3, specifically the “Classifying 
Asthma Severity Table”.139 The phenotype is a deterministic rule-based algorithm for 
children ages 5 to 18 and based on the following EHR data elements that align with the 
NAEPP EPR3 components of impairment for asthma severity: 1) prescribed asthma 
medications (Rx), 2) International Classification of Diseases codes (ICD-10), 3) percent 
predicted forced expiratory volume in one second (FEV1%) as a measure of lung 
function, and 4) asthma symptoms. Since the range of FEV1% values for intermittent and 
mild persistent are the same (>80%) according to NHLBI guidelines, the risk component 
of severity was integrated into the phenotype for these categories: annual corticosteroids 
were used to distinguish intermittent (0-1/year) from mild persistent (≥ 2/year). Asthma 
severity was assigned to asthmatic children in CHILD-DB based on the following EHR 





Rx: Medications prescribed to children with an asthma ICD-9 or ICD-10 code recorded 
in their chart were extracted from CHILD-DB. Medications were matched to generic or 
tradename for asthma medications obtained from the 2017 NAEPP EPR3 and 2019 
GINA Report (Table S3.2), flagged, and the associated medication Concept Unique 
Identifiers (RxCUIs) from the RxNorm141 ontology were identified. For all asthma 
medications except inhaled corticosteroids (ICSs), the RxCUI codes were categorized 
according to the medication class listed in Table S3.2. For ICSs, the medication 
instruction data field was also extracted to determine whether a patient was on a low, 
medium or high daily dose. Using the dosage indicated by the RxCUI code, the 
administrations per day that were mined from instructions, and the patient’s age, we 
determined the associated severity classification (Table S3.3).  
ICD-10: ICD-10 diagnosis codes conveying asthma severity (listed in Table 3.1) were 
identified (primary, secondary, admitting, or problem list.)  
FEV1%: The lowest FEV1% lab value in a given year was identified in accordance with 
the NAEPP ERP3 guidelines. The number of RxCUI codes for a systemic corticosteroid 
in a year was used to differentiate intermittent and mild persistent asthma since both are 
defined as <80% in the NAEPP ERP3.  
Symptoms: Asthma symptom data were available until 2015 when BMC transitioned 
from GE Centricity to Epic EHR software. Symptom data were collected in HDID fields 
(GE Centricity EHR software specific codes) as structured data or free-text, which were 
coded to correspond to a severity (e.g., “every day not all the time” in the structured 





Server 2008 as part of the Informatics for Integrating Biology with the Bedside Platform 
at Boston University (BU-i2b2).142 
In summary, severity was defined, per NAEPP EPR3 as the worst severity 
observed based on any of the four EHR data elements in the given year. For subjects who 
did not have severity ascertained, there was no EHR data element available in any of the 
four data elements (Rx, ICD-10, FEV1% and symptom severity). 
Data analyses 
Sample for analysis: A sample of the most recent five years of data (2013-2017) 
was created. There were 5,047 asthmatic children (contributing 14,054 patient-years) 
seen at BMC classified according to the Afshar et al. (2018)91 asthma phenotype during 
this time. A random, independent sample consisting of one year of data per patient was 
compiled for analysis (5,047 patients contributing 5,047 patient-years). The Mantel-
Haenszel chi-square test was used to assess the relationship between increasing severity 
and patient, visit, and documentation characteristics.  
Phenotype evaluation: The distribution of asthma severity among children at 
BMC produced by the asthma severity phenotype was qualitatively compared to what has 
been documented in the literature. Concordance assessments appropriate for paired, 
ordinal data were conducted (Weighted Kappa & McNemar Test of Direction of Change) 
to determine agreement and direction of change between pair-wise comparisons of the 
different EHR data elements (Rx, ICD-10, FEV1%, symptoms.)    
Influence of informed presence: To answer our questions about what data are 





dependent variables (severity ascertainment, the presence of long term Rx regimen, the 
presence of ICD-10 severity, the presence of a lung function test, the presence of 
symptom data) with independent variables (sex, age, race/ethnicity language spoken at 
home, number of years active, number of visits per year, asthma care during the year.) 
For the four models where EHR data elements were the outcome, data were restricted to 
patients for whom NHLBI severity was ascertained, ascertained severity was included as 
an independent variable, and if needed, data were restricted to the timeframe in which 
that element was available. Bivariate associations between dependent and independent 
variables that were statistically significant at p<0.05 (chi-square test results) were entered 
into the multivariable logistic regression models.  Candidate model variables were 
removed from the multivariable models using backward selection (p<0.05). Analyses 
were conducted in SAS 9.4 and using the Marginal Homogeneity Program v.1.2.143 
Results 
Severity phenotype 
Table 3.1 details the computable phenotype algorithm and Tables S3.1-S3.3 
provide standardized guidance and codes to implement the phenotype on EHR data. 
When the severity phenotype was applied to our random sample of independent severity-
years, severity was ascertainable for about half our random sample (n=2,461) (Table 3.2). 
For those patients for whom severity could be ascertained in our random sample, 80% of 
patients had Rx data, 50% had ICD-10 data, 26% had FEV1% data, and 17% had 
symptom data relevant to severity in a given year. The three most common combinations 





with severity data: 28% had Rx and ICD-10 data, 26% had Rx data only, and 12% had 
Rx, ICD-10, and FEV1% data. The more “complete” a patient’s severity data, the more 
years a patient was active during the study period, and the more visits a patient had in the 
year, the more severe their asthma was documented to be (Table 3.2). While differences 
in race/ethnicity and age existed across levels of severity, there were no significant 
differences in sex and language spoken at home (Table 3.2).   
Phenotype evaluation 
Overall distribution: The asthma severity computable phenotype produces a 
similar distribution in comparison to nationally representative and inner-city pediatric 
populations. Our study estimated 45% intermittent and 55% persistent asthmatics, as 
compared with 40% and 60% respectively in a national study.144 A sample of children 
from the National Cooperative Inner-City Asthma Study (of which BMC is a member) 
were found to be approximately 40% intermittent, 15% mild persistent, and 45% 
moderate or severe persistent.127 Our study had a similar distribution (45% intermittent, 
17% mild persistent, and 37% moderate or severe persistent).  
Concordance and direction of change analyses: Table 3.3 summarizes the 
results of assessments of pairwise comparisons between the four different EHR data 
elements that correspond to components of asthma severity, which can be compared with 
similar assessments from the clinical and claims literature.125–129 While categorization 
based on Rx and ICD-10 show moderate agreement, there is minimal agreement for all 
other pairwise comparisons (Table 3.3, weighted kappa). In regards to direction of 





which is generally more severe than when based on FEV1%, which is generally more 
severe than when based on symptom data (Table 3.3, McNemar Test). These findings 
agree with the clinical literature on asthmatic children that asthma severity classified by 
symptoms does not correlate well with FEV1% categorization128,129,145 and that 
classification is more severe when based on lung function and symptoms compared to 
symptoms only.127 Our results also agree with the claims-based literature, which finds 
that claims-based approaches categorize asthmatic patients as more severe compared to 
lung function measures126 or symptom-based approaches.125 Claims-based approaches 
can be considered loosely comparable to Rx and ICD-10 severity. 
Influence of informed presence 
Children for whom severity could be ascertained compared to children for whom 
severity could not were more likely to be: seen for asthma in the outpatient setting in a 
calendar year, younger (ages 5-11), White (compared to Hispanic), seen for any reason 
two or more times in a calendar year, and continually active patients for the five year 
period (Table 3.4). Among patients for whom severity could be ascertained, the presence 
of lung function test data, ICD-10 data, Rx data, and symptom data varied most by 
disease severity and asthma care pattern during the year. Asthma care pattern during the 
year was positively correlated with lung function data and ICD-10 data, whereas Rx data 
and symptom data were negatively correlated with asthma care pattern during the year. 
Severity was also positively correlated with lung function, ICD-10 and Rx data presence, 
but was negatively correlated with symptom data (Table 3.4). Symptom data and Rx data 





and lung function test data were not. Symptom data were positively correlated with all 
racial/ethnic groups relative to White children with Black and Other races attaining 
statistical significance; except for Hispanic children, lung function data were negatively 
correlated with all racial/ethnic groups relative to White, with Black race attaining 
statistical significance (Table 3.4).   
Discussion 
We created a clinically based and transportable136 computable phenotype for pediatric 
asthma severity based on EHR data because documentation of asthma severity in a 
standardized manner in the EHR is not common practice nor are clinical guidelines 
consistently implemented. Knowledge and selection of asthma clinical guidelines146, 
implementation146–148, and adherence to use of such guidelines147,148 by clinicians as well 
as a clear referral pathways from primary care to asthma specialists148 remain current 
challenges. We have documented an approach through which “big data” from the EHR 
can contribute to pediatric asthma research that is low-cost, standardized, leverages 
existing data, and does not add to clinician or clinical staff burden.  
Overall, the computable phenotype produces a distribution and behaves as expected 
in comparison to the literature and national statistics. As anticipated, children for whom 
severity could be ascertained were characteristically different in terms of their healthcare 
use and data documented, and ascertainment was also less likely among older and 
Hispanic children. Lastly, asthma severity based on different severity components (i.e., 
ICD-10 versus FEV1%) leads to different severity classifications for the same patient 





clinical research and claims data as well.126,129  
Disparities: Black children are four times more likely to suffer from severe persistent 
asthma compared to White children149, moreover, in our analysis they were less likely to 
have documentation of severity based on lung function testing in their EHR. 
Racial/ethnic differences in clinical documentation of asthma severity classification is a 
recognized barrier to eliminating racial disparities146 and may be an indicator of structural 
racism in health care. Our analyses of a largely urban, Black, pediatric population also 
highlight challenges outlined in the growing “big data” health disparities literature.150 
Fitzpatrick et al. (2019) found Blacks were less likely to receive outpatient care for 
asthma.151 Our study corroborates their findings: 1) we found Black children were more 
likely to have symptom data and less likely to have lung function testing; 2) lung function 
testing, but not symptom data, was positively and significantly associated with being seen 
for asthma in the outpatient setting. Uncovering such trends can inform clinical care 
management plans, interventions, and policies to reduce disparities.  
Clinical practice: The strength of the asthma severity computable phenotype is that it 
circumvents issues related to inconsistent documentation of asthma severity components 
and the use of varying asthma severity definitions by clinicians. The computable 
phenotype for asthma severity could be implemented as a clinically relevant and 
impactful population management tool, much like the patient-administered Asthma 
Control Test (ACT) score or the clinically-administered Patient Health Questionnaire 
(PHQ -2 or PHQ-9) for depression screening. The value of the ACT and PHQ are that 





severe asthmatics to target for intervention, with the added advantage that it can be 
automatically generated from existing EHR data. This application of the phenotype is 
valuable for EHR-based decision support and population health.  
Research: The influence of informed presence on data in the EHR relevant to asthma 
severity varies largely by disease severity, being seen for asthma, and being seen in the 
outpatient setting. This has significant implications in terms of what research questions 
are appropriate or not appropriate within EHR-based data analyses for pediatric asthma. 
For example, a traditional study may be better suited to conclude the true association 
between changes in FEV1% and ER visits for asthmatics since FEV1% is documented 
mainly for moderate and severe persistent asthmatics in the EHR. On the other hand, a 
longitudinal analysis of EHR data may be well-suited to advance our understanding of 
asthma remission and the evolution of illness trajectories (e.g., can patients “outgrow” 
asthma?)   
Clinical research: A clinical research area of particular importance and that EHR 
data may be ideally suited for is risk prediction of adverse events (exacerbations, death.) 
In regards to designing novel studies for risk prediction, the presence and absence of data 
in the EHR due to the healthcare process itself can be predictive of health status or 
adverse events.54,124 Asthma exacerbations are a significant contributor to morbidity and 
mortality across all levels of severity152, and the variation in the presence and absence of 
EHR asthma severity components could be exploited for risk prediction. The computable 
phenotype could contribute to differentiating risk factors for exacerbations across severity 






Epidemiological research: While statistical methods are well established to conduct 
valid and unbiased studies (i.e., methods for the common missingness patterns such as 
missing completely at random (MCAR) and missing at random (MAR)), the concept of 
informed presence when it comes to EHR data automatically disqualifies most traditional 
statistical methodologies since EHR data is not missing at random (NMAR). Our study 
showed increasing asthma severity and the number of EHR data elements with severity 
data (i.e., completeness of severity data) were associated, and there were racial/ethnic and 
healthcare utilization pattern disparities in the EHR data elements recorded relevant to 
severity. This is consistent with the broader literature, which shows that more complete 
records in EHRs are biased toward sicker patients50,154 or certain populations (older, 
female.)155  
Studies like ours are important to discover which missingness mechanisms exist as a 
result of informed presence NMAR patterns so researchers can address these patterns in 
traditional analyses42,43,55 and develop novel studies that creatively exploit the nature of 
EHR data. The epidemiological and informatics literatures are beginning to coalesce to 
create interdisciplinary solutions for “big data” health research.43,53,54 Both literatures 
have demonstrated approaches through which bias can be mitigated in EHR studies, 
ranging from the simple (adjusting for the number of health encounters55 or accounting 
for the context in which laboratory results are collected156) to utilizing a general 
framework to guide the research.53  





computable phenotype and not a validation study. While validation by clinically assessed 
(“gold standard”) chart review is a component of building a valid computable phenotype, 
our study emphasized the impact of unstandardized and inconsistent EHR data. The ICD-
10 code indicating severity was assigned by the clinician seeing the patient and can 
therefore be considered a reflection of clinically assessed severity, lending confidence to 
our findings, but future work should incorporate chart review as a key element prior to 
widespread utilization. 
In developing the severity phenotype, the time-scale of the phenotype (one calendar 
year) was a pragmatic choice and aligns with other population level, administrative 
timescales (i.e., HEDIS); however, other time-scales may be more clinically appropriate. 
The team was also guided by the NAEPP EPR3’s definition for asthma severity that is 
relevant to research: “For population-based evaluations, clinical research, or subsequent 
characterization of the patient’s overall severity, asthma severity can be inferred after 
optimal therapy is established by correlating levels of severity with the lowest level of 
treatment required to maintain control.” Thus, our study assumed the documented long-
term asthma medication regimen was the treatment required to maintain control. 
Additionally, this study was conducted at a single institution and not across multiple 
institutions/EHRs. While the phenotype was constructed largely from structured EHR 
data (versus unstructured EHR data), this limitation may not exist at other institutions to 
which this phenotype can be transported (i.e., those institutions may have the 
infrastructure and resources to leverage unstructured data through Natural Language 





classify severity may seem low, it is important to note that in the sample assessed, 40% of 
asthmatic patients did not receive care for asthma in the year their severity was assessed.  
Our study demonstrates the impact of visit and documentation processes on pediatric 
asthma severity at New England’s largest safety net hospital. Our pragmatic approach to 








Table 3.1 Asthma severity phenotype algorithm for pediatric patients ages 5-18  
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Medication prescription (Rx) 
Short-acting beta2-agonists (SABA) 
Inhaled Corticosteroid (ICS) 
Leukotriene receptor antagonists (LTRA) 
Long-acting beta2-agonists (LABA) 






Table 3.2 Sample characteristics by asthma severity ascertainment from EHR over 5-year 
period (n=5,047 patients) 
 No severity 
ascertained 
 












n 2,586 1,115 423 447 476  
Male (vs female) 1,490 (58%) 608 (55%) 236 (56%) 230 (52%) 274 (58%) 0.19 
Age: 5 to 11 (vs 12 to 
18) 1,205 (47%) 594 (53%) 288 (68%) 235 (53%) 352 (74%) 
<0.0001 
Race/ethnicity 0.009 
  Asian 70 (3%) 25 (2%) 15 (4%) 6 (1%) 6 (1%)  
  Black 1,479 (57%) 637 (57%) 219 (52%) 260 (58%) 257 (54%)  
  Hispanic 134 (5%) 22 (2%) 7 (2%) 11 (2%) 13 (3%)  
  Not Recorded 634 (25%) 329 (30%) 135 (32%) 121 (27%) 148 (31%)  
  Other 43 (2%) 15 (1%) 5 (1%) 3 (1%) 3 (1%)  
  White 226 (9%) 87 (8%) 42 (10%) 46 (10%) 49 (10%)  
English spoken at 
home (vs not 
English) 
1,975 (76%) 849 (76%) 318 (75%) 315 (70%) 375 (79%) 
0.58 
Duration of HCU (# years active) 0.0007 
  1      685 (26%) 246 (22%) 111 (26%) 121 (27%) 121 (25%)  
  2 640 (25%) 263 (24%) 99 (23%) 109 (24%) 94 (20%)  
  3 472 (18%) 177 (16%) 72 (17%) 68 (15%) 70 (15%)  
  4 372 (14%) 169 (15%) 53 (13%) 47 (11%) 71 (15%)  
  5 417 (16%) 260 (23%) 88 (21%) 102 (23%) 120 (25%)  
Total HCU (approx. quartiles: # visits/year) <0.0001 
  Q1 (30%): 1 visit 1,106 (43%) 242 (22%) 84 (20%) 63 (14%) 48 (10%)  
  Q2 (20%): 2 visits 517 (20%) 231 (21%) 82 (19%) 79 (18%) 80 (17%)  
  Q3 (30%):  3-5 
visits 655 (25%) 381 (34%) 153 (36%) 164 (37%) 165 (35%) 
 
  Q4 (20%): 6-45 
visits 308 (12%) 261 (23%) 104 (25%) 141 (32%) 183 (38%) 
 
Type of asthma specific HCU  <0.0001 
  Seen in OP for 
asthma* 325 (13%) 773 (69%) 325 (77%) 390 (87%) 434 (91%) 
 
  Seen in ER and/or 
IP only for asthma* 470 (18%) 170 (15%) 66 (16%) 43 (10%) 30 (6%) 
 
  No visit for asthma 








Table 3.2(continued) Sample characteristics by asthma severity ascertainment from 
EHR over 5-year period (n=5,047 patients) 
 No severity 
ascertained 
 












n 2,586 1,115 423 447 476  
# EHR elements with data (i.e., completeness of severity data) <0.0001 
  1 0 (0%) 722 (65%) 158 (37%) 98 (22%) 75 (16%)  
  2 0 (0%) 368 (33%) 225 (53%) 235 (53%) 191 (40%)  
  3 0 (0%) 25 (2%) 38 (9%) 109 (24%) 205 (43%)  
  4 0 (0%) 0 (0%) 2 (<1%) 5 (1%) 5 (1%)  
Severity data present in specific EHR element  
Rx – long term 
regimen present (vs 
not) 
0 (0%) 735 (66%) 377 (89%) 391 (87%) 471 (99%) <0.0001 
ICD-10 severity** 
present (vs not) 0 (0%) 414 (37%) 243 (57%) 283 (63%) 302 (63%) <0.0001 
FEV1% present (vs 
not) 0 (0%) 133 (12%) 70 (17%) 182 (41%) 253 (53%) <0.0001 
Symptoms 
present** (vs not) 0 (0%) 251 (23%) 40 (9%) 59 (13%) 66 (14%) <0.0001 
Notes: *Seen in the outpatient setting for asthma = OP, IP & ER; OP & ER; OP & IP; OP only. Seen in ER 
and/or IP only for asthma = ER & IP; ER only; IP only 
**ICD-10 asthma codes with severity indication were implemented in 2015 and the EHR form used to 
record asthma symptom data was discontinued in 2015 
***MH test is inclusive of no severity ascertained category
Abbreviations:  
MH: Mantel-Haenszel  
HCU: healthcare use 
OP: outpatient visit 
IP: inpatient visit 






Table 3.3 Concordance and direction of change of pair-wise comparisons of EHR data 
elements representing asthma severity  
  # patients with 
data in both 
EHR elements 
Weighted Kappa McNemar Test of Direction of 
Change Interpretation* 
Rx & ICD-10** 1,002 0.46 (0.42,0.50) Rx severity > ICD-10 severity 
Rx & FEV1% 502 0.05 (0.01,0.09) Rx severity > FEV1% severity 
Rx & symptoms** 227 0.07 (0.02,0.12) Rx severity > symptom severity 
ICD-10** & 
FEV1% 




34 0.09 (-0.07,0.25) ICD-10 severity > symptom 
severity 
FEV1% & 
symptoms** 114 -0.11 (-0.18,-0.04) 
FEV1% severity > symptom 
severity 
Notes: * The McNemar Test of Direction of Change is a non-parametric test used to evaluate changes in 
directionality of paired data. In this case, it indicates whether the proportion of patients in the four severity 
levels differed when based on a different EHR data element. ”>” is interpreted as “generally higher than” 
(e.g., for the first result, severity based on Rx is generally higher than when severity is based on ICD-10.) 
All McNemar results were significant at p < 0.05. 
**ICD-10 asthma codes with severity indication were implemented in 2015 (backdating of ICD10 codes is 





Table 3.4 The influence of informed presence on severity ascertainment and data 
elements relevant to asthma severity 
 Multivariable Models 


















Total n 5,047 2,461 1,625 2,461 836 
  Data Present  2,461 1,974 1,179 638 378 
  Not Present 2,586 478 446 1,823 458 
Age: 5 to 11  
(vs 12 to 18) 
1.66 
(1.42,1.94) 
    
Race/ethnicity      
  Asian 0.76 
(0.43,1.34) 
  0.53 
(0.22,1.30) 
1.65 (0.43,6.27) 
  Black 0.97 
(0.73,1.28) 
  0.47 
(0.32,0.69) 
2.37 (1.26,4.48) 
  Hispanic 0.47 
(0.29,0.77) 




  Not Recorded 1.08 
(0.80,1.46) 
  0.69 
(0.47,1.03) 
1.62 (0.83,3.18) 
  Other 0.61 
(0.29,1.27) 




  White Reference   Reference Reference 
# years active      
  1      Reference    Reference 
  2 1.02 (0.82, 
1.27) 
   0.94 (0.59,1.49) 
  3 0.81 
(0.64,1.04) 
   0.92 (0.54, 
1.58) 
  4 0.95 
(0.73,1.24) 
   1.91 (1.18,3.10) 
  5 1.30 
(1.01,1.66) 
   2.41 (1.54,3.79) 
# visits/year      
  1 visit Reference Reference    




   




   













Table 3.4 (continued) The influence of informed presence on severity ascertainment and 
data elements relevant to asthma severity 
 Multivariable Models 


















Total n 5,047 2,461 1,625 2,461 836 
  Data Present  2,461 1,974 1,179 638 378 




     
  Seen in OP 
for asthma 
 0.40 (0.27,0.58) 253 (97,663) 12 (5,29) 1.34 (0.83,2.15) 
    OP, IP & 
ER 
102 (31,334)     
    OP & ER 46 (32,68)     
    OP & IP 49 (27,89)     
    OP only 39 (32,47)     
  Not seen in 
OP for asthma 
 1.64 (0.98,2.75) 26 (10,67) 0.27 (0.06, 
1.27) 
0.13 (0.05,0.35) 
    ER & IP 13 (7,24)     
    ER only 4 (3,5)     
    IP only 11 (8,15)     
  No visit for 
asthma  
Reference  Reference Reference Reference Reference 
Severity N/A     
  Intermittent  Reference Reference Reference Reference 















Notes: Bold: p<0.05 
*ICD-10 asthma codes with severity indication were implemented in late 2015 so data reflected is for 
2016-2017 
** Lung function test present means that there was a lung function test done and there is a recorded 
FEV1% in the patient’s record. 
***the EHR form used to record asthma symptom data was discontinued in 2015 so data reflected is for 
2013-2014 
^^In the first column (severity ascertained versus not logistic model), the variable “Asthma care during 
year” is made up of 8 categories: from the reference category of “No visit for asthma” up to “OP, IP & 
ER”; however, for the remaining models, the variable has been collapsed into 3 categories: No visit for 














Table S3.1 Exclusionary criteria used to classify children as asthmatic, based on a 
published asthma phenotype (Afshar et al. 2018) and updated to include corresponding 
ICD-10 codes  
Afshar et 
al. (2018)1  
ICD-9 
codes 
ICD-9 description  Corresponding ICD-10 ICD-10 description
2,3 
428.x Heart failure I50.x Heart failure 
359.x 
Muscular dystrophies and 
other myopathies 
G71.x Primary disorders of muscles 
G72.x Other and unspecified myopathies 
335.x 
Spinal muscular Atrophy and 
other motor neuron diseases 
G12.x Spinal muscular atrophy and related syndromes 
343.x Cerebral palsy G80.x Cerebral palsy 
V58.44 
Aftercare following organ 
transplant 
Z48.298 
Encounter for aftercare following other organ 
transplant 
V49.83 
Awaiting organ transplant 
status 
Z76.82 Awaiting organ transplant status 
V42.x 
Organ or tissue replaced by 
transplant 
Z94.x Transplanted organ and tissue status 
Z95.x Presence of cardiac and vascular implants and grafts 
E878.0 
Surgical operation with 
transplant of whole 
organ 
Y83.0 
Surgical operation with transplant of whole organ 
causing abnormal patient reaction, or later 
complication, without mention of misadventure at 




T86.x Complications of transplanted organs and tissue 
714.x 
Rheumatoid Arthritis and 
other inflammatory 
polyarthropathies 
M06.x Other rheumatoid arthritis 
M05.x Rheumatoid arthritis with rheumatoid factor 
M08.x Juvenile arthritis 





M32.x Systemic lupus erythematosus (SLE) 
M34.x Systemic sclerosis [scleroderma] 






D47.Z1 Post-transplant lymphoproliferative disorder (PTLD) 




weeks). 765.28 and 765.29 
are allowed. 
P07.21 to P07.26 and 
P07.31 to P07.37 





Chronic respiratory disease originating in the 
perinatal period 
V81.3 
Chronic bronchitis and 
emphysema 




P22.0 Respiratory distress syndrome of newborn 
748.2  to 
748.9 
Congenital abnormalities of 
lower airways and lungs 
Q31 Congenital malformations of larynx 
Q32 Congenital malformations of trachea and bronchus 
Q33 Congenital malformations of lung 
Q34 Other congenital malformations of respiratory system 










Table S3.1(continued) Exclusionary criteria used to classify children as asthmatic, based 
on a published asthma phenotype (Afshar et al. 2018) and updated to include 
corresponding ICD-10 codes 
Afshar et 
al. (2018)1  
ICD-9 
codes 
ICD-9 description  Corresponding ICD-10 ICD-10 description
2,3 
517.x 
Lung involvement in 
conditions classified 
elsewhere 
J17 Pneumonia in diseases classified elsewhere 
M34.81 Systemic sclerosis with lung involvement 
J99 Respiratory disorders in diseases classified elsewhere 
516.x 
Other alveolar and 
parietoalveolar 
pneumonopathy 
J84.x Other interstitial pulmonary diseases 
515 Pulmonary fibrosis J84.x Other interstitial pulmonary diseases 




radiation lung disease 




J44.9 Chronic obstructive pulmonary disease, unspecified 
495.x Extrinsic allergic alveolitis J67.x Hypersensitivity pneumonitis due to organic dust 
494.x Bronchiectasis J47.x Bronchiectasis 
492.x Emphysema J43.x Emphysema 
491.x 
Chronic obstructive 
pulmonary disease [COPD] 
J41.x Simple and mucopurulent chronic bronchitis 
J44.x Other chronic obstructive pulmonary disease 
J42.x Unspecified chronic bronchitis 
478.5 
Other diseases of vocal cords 
(Vocal Cord 
Dysfunction) 
J38.3 Other diseases of vocal cords 
478.3x 
Paralysis of vocal cords or 
larynx 
J38.00 Paralysis of vocal cords and larynx, unspecified 
J38.01 Paralysis of vocal cords and larynx, unilateral 
J38.02 Paralysis of vocal cords and larynx, bilateral 
416.x 
Chronic Pulmonary Heart 
Disease 
I27.x Other pulmonary heart diseases 
415.x 
Acute Pulmonary Heart 
Disease (cor pulmonale, 
embolism) 




Cystic Fibrosis and other 
metabolic disorders 
E84.x Cystic fibrosis 
E80.x Disorders of porphyrin and bilirubin metabolism 
E79.x Disorders of purine and pyrimidine metabolism 
E85.x Amyloidosis 
E76.x Disorders of glycosaminoglycan metabolism 
D84.1 Defects in the complement system 
E88.x Other and unspecified metabolic disorders 
E71.x 
Disorders of branched-chain amino-acid metabolism 
and fatty-acid metabolism 
H49.81x Kearns-Sayre syndrome 
C96.5 
Multifocal and unisystemic Langerhans-cell 
histiocytosis 
C96.6 Unifocal Langerhans-cell histiocytosis 
273.4 
Alpha 1- antitrypsin 
deficiency 
E88.01 Alpha 1- antitrypsin deficiency 
V08 and 
795.71 
Asymptomatic & serologic 
HIV infection 
Z21 
Asymptomatic human immunodeficiency virus [HIV] 
infection status 
R75 
Inconclusive laboratory evidence of human 
immunodeficiency virus [HIV] 
079.5x Retrovirus infections 
B97.3x 
Retrovirus as the cause of diseases classified 
elsewhere 





Table S3.1(continued) Exclusionary criteria used to classify children as asthmatic, based 
on a published asthma phenotype (Afshar et al. 2018) and updated to include 
corresponding ICD-10 codes 
Afshar et 
al. (2018)1  
ICD-9 
codes 





virus [HIV] disease 
B20 Human immunodeficiency virus [HIV] disease 
212.3 Benign neoplasm of the bronchus and lung D14.30 




Cancers of lymphatic 
and hematopoietic 
systems 
C83.x Non-follicular lymphoma 
C84.x Mature T/NK-cell lymphomas 
C81.x Hodgkin lymphoma 
C82.x Follicular lymphoma 
C96.x Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue 
C91.x Lymphoid leukemia 
C85.x Other specified and unspecified types of non-Hodgkin lymphoma 
C90.x Multiple myeloma and malignant plasma cell neoplasms 
C88.x Malignant immunoproliferative diseases and certain other B-cell lymphomas 
C92.x Myeloid leukemia 
C93.x Monocytic leukemia 
C94.x Other leukemias of specified cell type 
D45 Polycythemia vera 




neoplasm of respiratory 
system 
C78.0 to C78.3 Secondary malignant neoplasm of respiratory system 
160.x to 
165.x 
Cancers of airways and 
thorax C30 to C39 









Table S3.2 Generic and trade names of medications for asthma treatment according to 
national and international clinical guidelines  
Medication class4,5 Generic name(s)4,5 Trade name(s)1,6 
Long-term control medications   
Inhaled corticosteroids (ICSs) 
beclomethasone HFA/MDI Qvar, Vanceril 
budesonide DPI Pulmicort 
budesonide nebules  
ciclesonide MDI Alvesco 
flunisolide MDI Aerobid 
flunisolide HFA Aerospan 
fluticasone HFA/MDI Arnuity, Breo, Armonair, Airduo 
fluticasone DPI Flovent 
mometasone DPI Asmanex 
triamcinolone acetonide Azmacort 
Oral systemic corticosteroids 
methylprednisolone Medrol 
prednisolone Millipred, Pediapred, Orapred, Veripred, Flopred 
prednisone Deltasone, Rayos 
Cromolyn sodium and nedocromil cromoyln or nedocromil Intal, Tilade 
Immunomodulators omalizumab Xolair 
Leukotriene modifiers -  




Leukotriene modifiers-  
5-lipooxygenase inhibitor zileuton Zyflo 
Long-acting beta2-agonists 
(LABAs) 
salmeterol Airduo, Serevent 
formoterol Foradil 






Quibron-t, Elixophyllin, Theo-24, 
Theochron, Uniphyl, Slo-bid, Theo, 
Theodur 
Quick-relief medications   
Anticholinergics ipratropium bromide Combivent, Duoneb 
Inhaled short-acting beta2-
agonists (SABAs) 
albuterol Proventil, Vospire, Combivent, Accuneb, Ventolin, Duoneb, Proair 
levalbuterol Xopenex 
pirbuterol Maxair 
Oral or injection systemic 
corticosteroids 
methylprednisolone Medrol 
prednisolone Millipred, Pediapred, Orapred, Veripred, Flopred 
prednisone Deltasone, Rayos 









Table S3.3 Inhaled Corticosteroids (ICSs): Estimated comparative daily dosages  
ICS 
5 to 11 years old 
dosage (mcg) 
≥12 years old dosage 
(mcg) ICS daily dose category 
Fluticasone MDI7  
88-176 88-264 low 
>176-352 >264-440 medium 
>352 >440 high 
Fluticasone DPI7  
100-200 100-300 low 
>200-400 >300-500 medium 
>400 >500 high 
Mometasone DPI7  
110 110-220 low 
220-440 >220-440 medium 
>440 >440 high 
Beclomethasone MDI7  
80-160 80-240 low 
>160-320 >240-480 medium 
>320 >480 high 
Budesonide DPI7  
180-360 180-540 low 
>360-720 >540-1080 medium 
>720 >1080 high 
Budesonide Nebules7  
500 NA low 
1000 NA medium 
2000 NA high 
Ciclesonide MDI7  
80-160 160-320 low 
>160-320 >320-640 medium 
>320 >640 high 
Flunisolide MDI7  
160 320 low 
320-480 >320-640 medium 
>480 >640 high 
Triamcinolone5  
400-800 400-1000 low 
>800-1200 >1000-2000 medium 
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There is growing recognition in the social and geographical sciences that 
enriching the conceptualization of residential mobility may advance our understanding of 
its impact on health and well-being. As sources of health and address data, electronic 
health record (EHR) systems may support our ability to characterize residential mobility 
across large study populations in more nuanced ways, but with some challenges in 
interpreting the available data. In this study, we propose multiple residential mobility 
metrics that draw from the social, geospatial, and data science fields and identify 
opportunities and limitations associated with using data derived from the EHR. Next, we 
conduct descriptive analyses of contextualized residential mobility (and immobility) and 
demographic characteristics using data on 56,050 children seen at Boston Medical 
Center, New England’s largest safety-net hospital, from 2013-2017. EHR address data 
reveal significant racial/ethnic disparities in access to neighborhood opportunity that 
contributes to healthy child development. Using definitions of neighborhood opportunity 
derived from the Child Opportunity Index 2.0 (COI), Hispanic (adjusted Odds Ratio 
(aOR)=9.57) and Black (aOR=9.37) children are significantly more likely to experience 
“low opportunity” moving compared to White children. Among children who moved 
during our study period, Hispanic (aOR=4.47) and Black (aOR=3.66) children are 
significantly more likely to move to or within low opportunity neighborhoods. Among 
non-movers, Hispanic (aOR=9.27) and Black (aOR=7.16) children are much more likely 
to live in low opportunity neighborhoods. Our findings, based in EHR address data, 





children. Despite the limitation of these data, including issues related to informed 
presence, our analyses suggest that they could be leveraged to inform interventions in the 
clinical setting as well as inform local policy solutions to advance health equity and 







While the association between residential mobility in childhood and health has 
been widely studied76, a growing body of literature rooted in the social sciences 
advocates for a re-conceptualization of residential mobility to advance our understanding 
of its impact on health and well-being.94,95,157,158 Within the health literature, residential 
mobility has often been quantified as the number of moves or as a dichotomous variable 
(mover versus non-mover).76,159–161 Yet research has shown (see Figure 4.1162) that it is 
not the residential moves per se themselves that are detrimental but rather the economic 
or familial changes that initiate the move, or the consequent neighborhood, peer, and 
school context transitions associated with residential mobility that impact many facets of 
child development.76,160–168 Changes in residence and changes in school are life events 
that can be significant sources of stress169, and both are associated with poor educational 
outcomes.170,171 Morris et al. (2018) discussed key shortcomings that need to be improved 
to advance the residential mobility health literature: how mobility is categorized (i.e., the 
theoretical basis), the influence of time and critical periods, as well as the context of 
moves and the nature of residential moves as positive or negative experiences.95 The 
authors state that the “underlying assumption that there are one-to-one relationships 
between staying and good health and moving and bad health [is] a reductionist view 
that…implies homogeneity within mobility groups. This has rarely been challenged yet 
such a dichotomy cannot be correct because residential stability may not be beneficial if 
people are unable to ‘escape’ an area”.95 Similarly, Coulter et al. (2016) emphasized the 





needs to be explored in-depth and thought of as a relational practice.94  
There is a growing literature that moves dichotomous questions (i.e., “does 
residential mobility or neighborhood context matter for well-being?”94,95,158) and 
embraces multidimensionality by asking instead: for whom, where, when and why does 
mobility and context matter?  In a study across 10 cities in the United States, Coulton et 
al. (2012) identified sub-groups of movers and non-movers for whom their mobility 
could be interpreted as positive (e.g., up-and-out movers and positive stayers) and 
negative (e.g., churner movers and dissatisfied stayers.172) For instance, evidence shows 
that moving to neighborhoods that are more desirable can have a positive effect on 
educational attainment of adolescents that varies by race and social class.173 However, 
low-income families (particularly Black low-income families) who remain in low 
opportunity neighborhoods and schools experience repeated moves in response to urgent 
and unpredictable emergencies such as housing quality failure, income changes, or 
neighborhood violence. Such moves can have adverse effects as moves are made without 
first considering options for school and job opportunities.174,175 In a recent study on 
kindergarten readiness, the multidimensionality of residential mobility was explicitly 
operationalized through frequency and number of moves, move distance, move context, 
and move quality revealing the importance of contextualizing residential mobility to 
understand its impact on child well-being.168,176  
With growing availability of country-wide health data in single payer health 
systems, health studies are beginning to adopt a more nuanced view of residential 





Danish study on mental health integrated time and timing into their definition of 
childhood residential mobility, supporting a life course approach to analysis.177 A study 
in the United Kingdom identified more heterogeneity among non-movers—a grouping 
rarely deconstructed—than movers, and suggesting that the dichotomy of movers versus 
non-movers is insufficient to study mental health outcomes among children.178 Lastly, a 
nationwide study in New Zealand examined the risk of cardiovascular events by 
classifying participants’ residential mobility as upward, downward, or lateral based on 
area deprivation scores.179  
Although there have been advancements in the literature, it remains challenging to 
characterize the health implications of residential mobility and immobility among large 
populations, especially in countries like the United States that lack a single payer 
healthcare system. However, big data, such as data from EHRs, have the potential to 
support our ability to characterize residential mobility in more nuanced ways as they are 
sources of health data and address data. In the United States, widespread adoption of 
electronic health record (EHR) systems has been achieved in recent years.32 As of 2017, 
96% of hospitals and 80% of office-based physicians have adopted a government 
certified EHR.32 Address data in the EHR generally reflects information provided by 
patients at the time of an office visit as part of the registration process or from the billing 
portion of the EHR system. As a result, a wealth of place-based population health studies 
in which health data in the EHR is linked to external datasets based on address data in the 
EHR are available.11,12,68–71 In this study, we aimed to enrich the conceptualization and 





opportunities and challenges these data source offer. To apply our approach, we also 
characterized residential mobility and immobility alongside neighborhood opportunity in 
relation to demographic characteristics on children attending an urban safety-net hospital.  
Methods  
Scoping phase: literature review, synthesis, and identification of gaps 
We reviewed select literature on residential mobility in the social sciences and 
health literature. We focused on topical papers on the conceptualization and shortcomings 
of residential mobility research94,95,158 so as to identify recent papers that operationalized 
residential mobility differently168,172,176–179 than older studies.76 Next, we synthesized the 
knowledge from the papers reviewed and the team’s expertise in EHR data and geospatial 
methods (summarized in Table 4.1) to answer the following question: how can EHR data 
be operationalized to produce hypothesis-generating knowledge on different dimensions 
of residential mobility? Ultimately, we applied proposed metrics by carrying out our 
residential mobility analyses on EHR data from an urban safety-net hospital (detailed in 
the next sections.) In addition, we discovered important gaps in the EHR and geospatial 
literatures that impacted our ability to explore mobility metrics for frequency of moving, 
moving distance, and “highly mobile” categorization at the granularity of residence and 
highlighted these roadblocks. In our final analyses, we used metrics relevant to the 
following two dimensions of residential mobility: context of moving and residential 
immobility.  
Study population 





Center (BMC), Boston, Massachusetts, USA from 2013 to 2017 whose address data was 
captured from the BMC EHR. BMC is New England’s largest safety-net hospital and 
serves a predominantly low-income and racially/ethnically diverse population. This 
cohort is a subset of the CHIL-DB database of children ages 18 years and under compiled 
for the Asthma Simulation Tool for Housing, Medication, and Social Adversity 
(ASTHMA) Study180 from the larger Informatics for Integrating Biology with the 
Bedside Platform at Boston University database (BU-i2b2) and BMC Clinical Data 
Warehouse.142 The following criteria were applied to the five most recent and complete 
years of EHR data in the database (2013-2017) to create a cohort of children for analyses: 
1) at least two visits (inpatient, outpatient, or emergency visit) at BMC during the study 
period; 2) at least 1 geocoded address at the parcel level on file that had a date-time 
stamp either beginning or ending during the study period. Figure 4.2 depicts in detail, the 
derivation of the final cohort for analysis (n=56,050). All protocols were reviewed and 
approved by the Boston University Medical Campus Institution Review Board. 
Address data and geocoding 
The cascade matching geocoding method was used to geocode the addresses on 
file in the EHR for the entire ASTHMA cohort by using both the MassGIS Statewide 
Master Geocoder181 and the ESRI ArcGIS World Geocoder in ArcMap (version 10.7). 
96% of addresses were geocoded to a point or street address, the most granular level of 
geocoding. All addresses that were successfully geocoded were assigned parcel, Census 
block group, and Census tract identifiers for linkage to additional geospatial datasets 





addresses to be geocoded down to the parcel level and excluded patients who had 
addresses on file with overlapping timeframes to reduce misclassification and ensure 
accurate classification of movers and non-movers. 
Independent variables 
Demographic characteristics: Patient race/ethnicity (Asian, Black, Hispanic, Not 
Recorded, Other, and White), language spoken at home (English or Non-English), and 
sex (female or male) were extracted from CHIL-DB. Age, based on a patient’s average 
age during this study’s follow-up period, was also extracted. Race/ethnicity was a 
combined field in the EHR, so Hispanic ethnicity could not be specifically separated from 
race. Patients who had missing race/ethnicity data were included and are coded in the 
EHR as “Not Recorded”.   
Active patient characterization: The cohort we assembled for analysis was an 
open cohort and as a result patients varied in regards to their follow-up time during the 
study. We calculated the number of years a patient was considered an active patient at 
BMC during the study period (1-5 years.) A patient was considered “active” if they had a 
visit in a given year.  
Census tract opportunity characterization: The neighborhood context of 
geocoded addresses was characterized at the census-tract level by linking to the Child 
Opportunity Index 2.0 (COI).185 The COI is an index of neighborhood resources and 
conditions that foster healthy child development; the COI combines 29 neighborhood-
level indicators across three opportunity domains (education, health and environment, 





tract level 2015 state-normed COI quintiles (very low, low, moderate, high, and very high 
opportunity) into two categories for our analyses: low opportunity census tracts (very low 
and low quintiles) and opportunity census tracts (moderate, high, and very high 
quintiles.)  
Dependent variables 
Moving status: As depicted in Figure 4.2, patients with only one unique address 
on file in the EHR during the study period were classified as non-movers and patients 
who had more than one unique geocoded address on file in the EHR during the study 
period were classified as movers.  
Contextualized mobility metrics: Using the census tract opportunity 
characterization described above, non-movers were classified as low opportunity non-
movers or opportunity non-movers based on their one unique address on file in the 
EHR. Among movers, there are numerous ways in which children could move among 
neighborhoods. For the purposes of this analysis, we focused on the characteristics of the 
census tract from their last address on file at the EHR, informed by the literature on EHR 
address data quality.75 Movers were classified as experiencing opportunity moving (if 
their last address on file in the EHR was in an opportunity census tract) or low 
opportunity moving (if their last address on file in the EHR was in a low opportunity 
census tract), regardless of the known attributes of previous addresses on file.  
Statistical analyses 
First, bivariate tests (chi-square and Wilcoxon tests) were carried out to determine 





non-mover.) Second, we ran a series of univariate logistic regression models in which 
race/ethnicity was the independent variable (adjusted for active patient status only) since 
no other demographic characteristics (age, sex, or language spoken at home) were 
significant at p<0.05 in bivariate tests. In logistic regression models, we a priori decided 
to control for the potential positive correlation between moving and the length of time a 
patient was followed during the study (active patient characterization.) To explore 
demographic associations with residential mobility, we specified three sets of logistic 
regression models: 1) for the total population, a comparison between movers and non-
movers (for the total population, those whose last address on file was in a low 
opportunity census tract, and those whose last address on file was in an opportunity 
census tract); 2) for the subset of non-movers, a comparison between those who remained 
in low opportunity census tracts vs. those who remained in opportunity census tracts; 3) 
for the subset of movers, a comparison between those who moved to low opportunity 
census tracts vs. those moved to opportunity census tracts. Sensitivity analyses for the 
logistic regression models were conducted in which patients who were only considered 
active for 1 year were excluded (since they are considered active if they were seen at 
BMC for either <1 to 12 months.) All data were extracted from CHIL-DB using 
Microsoft SQL Server 2008 and all analyses were conducted in SAS 9.4. 
Results  
Characterization of residential mobility  
Dimensions of residential mobility as well as current opportunities to 





In this study we were able to study two dimensions of residential mobility (context of 
moving and residential immobility), using geocoded addresses and the COI. In the 
process of implementing mobility metrics on the frequency of moving, moving distance, 
and highly mobile categorization, we encountered the following barriers: patients had 
addresses on file with overlapping timeframes, dummy addresses existed (e.g., patient 
refused, homeless), and some patients could not be geocoded at the parcel level (see 
Figure 4.2). Additionally, through clinical conversations, it was clear that some key 
information related to residential stability (e.g., patients reporting to their clinician that 
they are living in their car or facing eviction) may be documented in clinical notes but not 
the registration information from which EHR addresses are derived. Thus, to study the 
dimension of mobility motives/triggers, advanced technologies (natural language 
processing) requiring large teams and resources are necessary to mine clinical notes and 
were not available in our safety-net hospital setting.  
By consulting the literature as we encountered challenges, it became clear that 
knowledge on EHR address data acquisition, structure, and processing, and the 
implications for data quality have not been fully characterized in the geospatial EHR 
literature.12,13,186,187 To aid in attenuating data quality concerns on health data in EHRs, 
practices such as the use of computable phenotypes have been studied in depth and 
widely implemented,39–41 and the concept of informed presence has come to fruition.42,43 
Informed presence posits that data in the EHR are not random (an assumption of many 
study methodologies) and may not reflect the underlying disease that researchers are 





system interactions and documentation (or lack thereof).48 Unless mitigated, the potential 
for bias and lack of validity when using EHR data is significant in research.49–52 EHR 
address data and what they can reveal about residential mobility are not exempt from the 
impact of informed presence bias (i.e., patients interact with the health care system at 
specific times and if residential instability itself impacts care access188, EHR address data 
are not missing at random), and to our knowledge, no studies exist on the topic. These 
discoveries during the study process combined with the lack of literature on EHR address 
data quality and the impact of informed presence on EHR address data led us to examine 
only a subset of our proposed metrics for which quality data currently exist. 
Patient characteristics 
There were 56,050 children seen for at least two visits at BMC from 2013 to 2017 
(Table 4.2). Children were on average eight years of age. The majority were either Black 
(39%) or their race/ethnicity was not recorded (34%). 34% did not speaking English at 
home, and 62% of patients were considered active at BMC for 1 or 2 years. Based on 
their last geocoded address on file in the EHR during their time of follow-up, the majority 
of children lived in a low opportunity census tract (80%) and 35% of children were 
classified as movers during the study period. There were statistically significant 
differences between movers and non-movers across race/ethnicity, years active at BMC 
during the study period, and census tract opportunity, and no statistically significant 
differences as a function of sex, average age, or language spoken at home (Table 4.2). 





of the non-movers were classified as low opportunity non-movers and 83% of the movers 
were classified as experiencing low opportunity moving.  
Exploring demographic associations with contextualized residential mobility metrics  
Movers versus non-movers: The odds of moving versus not moving differ 
between non-White and White children (Model 1, Table 4.4). Black and Hispanic 
children are more likely to move compared to their White counterparts (aOR: 1.60 and 
1.21, respectively) (Model 1, Table 4.4). Asian children are less likely to move compared 
to their White counterparts (aOR: 0.87) (Model 1, Table 4.4). For the subset of the 
population whose last address on file was in a low opportunity census tract, all 
races/ethnicities compared to White are significantly less likely to experience opportunity 
moving than remain in low opportunity neighborhoods (aOR range: 0.21-0.81) (Model 2, 
Table 4.4). For the subset of the population whose last address on file was in a low 
opportunity census tract, all races/ethnicities except Asian compared to White are 
significantly more likely to experience low opportunity moving than remain in 
opportunity neighborhoods (aOR range: 1.96-9.57) (Model 3, Table 4.4).    
Within movers and within non-movers: Examining the subset of non-movers in 
more detail, non-white children were significantly more likely to remain in low 
opportunity neighborhoods than remain in opportunity neighborhoods compared to White 
children (aOR range: 1.48-9.27) (Model 4, Table 4.4). For the subset of movers, all 
races/ethnicities except Asian compared to White are significantly more likely to 
experience low opportunity moving than opportunity moving (aOR range: 1.60-4.47) 





Children with missing race/ethnicity (“No Race Recorded”) or Other 
race/ethnicity: Similar to Black and Hispanic children, children with missing 
race/ethnicity data are more likely to move compared to their White counterparts (aOR: 
0.86) (Model 1, Table 4.4). Similar to Asian children, Other race/ethnicity children are 
less likely to move compared to their White counterparts (aOR: 0.87) (Model 1, Table 
4.4). In all models, adjusted ORs for children with missing race/ethnicity data were 
stronger than for Other race/ethnicity children.    
Results of sensitivity analyses excluding patients who were active for only one 
year at BMC during the study period were similar to primary results; however, results for 
Hispanic children were slightly attenuated except for the model examining a subset of 
movers (Supplemental Table 4.1).  
Discussion  
In this study we proposed multiple residential mobility metrics that draw from the 
social, geospatial, and data science fields identifying opportunities and limitations 
associated with using data derived from the EHR to explore residential mobility. Using a 
subset of metrics that could be readily characterized using EHR data, we characterized 
residential mobility (and immobility) with respect to the neighborhood context, revealing 
significant racial/ethnic disparities in access to neighborhood opportunity that contributes 
to healthy child development.  
Findings on Black and Hispanic children: Our findings reinforce a familiar 
commentary for racial/ethnic minority children, particularly Black and Hispanic children, 





child development.189,190 We observe stark disparities for Black and Hispanic children in 
living in and moving to or within higher opportunity areas. These children face 
significantly lower odds of experiencing opportunity moving than remaining in low 
opportunity areas and significantly higher odds of low opportunity moving compared to 
White children. In the literature, residence in poor or disadvantaged communities has 
been shown to be common and multigenerational for Black families in the US; more than 
70% of Black children versus 40% of Whites living in the poorest quartile of US 
neighborhoods remained in such neighborhoods as adults.191 Our findings highlight the 
perpetuation of residence in low opportunity areas among non-White children. 
Turning to our findings on subsets of non-movers, Black and Hispanic children 
are significantly more likely to be “stuck” in low opportunity areas compared to White 
children. Using the COI 2.0 Score, Acevedo-Garcia et al. (2020) found that in the 100 
largest metropolitan areas in the US, White and Asian/Pacific Islander children had a COI 
score over twice that of Hispanic children and three times that of Black children.192 
Similarly, a race and inequality report found a low-income Black person and low-income 
Hispanic person were three and two times as likely, respectively, to live in higher poverty 
neighborhood compared to a White person.193 Severe racial disparities in which Black 
and Latino families experience long-term, uninterrupted exposure to disadvantaged 
neighborhoods compared to White families are well-documented194–196; Timberlake 
(2007) estimates an average Black, Latino, and White child spends 50%, 40%, and 5% of 
their childhood in poor neighborhoods. Our findings on subsets of movers, confirm 





with an increased probability of experiencing negative mobility.163 Blacks and Latinos 
were also more likely to experience negative mobility and less likely to experience 
positive mobility, which may be related to difference in geographic proximity to 
family.197 Lastly, the structural racism of historic redlining has created differences in 
opportunities in neighborhoods and racialized health inequities of today.198   
Children with missing race/ethnicity data (“No Race Recorded”): In our 
sample, 50% of children with no race/ethnicity recorded were Non-English speakers at 
home (data not shown). Given the political climate in the US around undocumented 
(largely Hispanic) immigrants during the period of our study, given that BMC is a safety-
net hospital and based on the study described below, we suspect the no race/ethnicity 
recorded category is reflective of Hispanic and Black children who are most vulnerable. 
Moreover, in models where ORs for Hispanic children were attenuated in sensitivity 
analyses, aORs for No Race Recorded children were strengthened. Our findings are 
similar to a recent study that found that patients with no race/ethnicity in their structured 
EHR data (used in this study) were significantly different from those with race/ethnicity 
documentation199. Specifically, unstructured data led to a 26% and 20% increase in 
ascertainment of race/ethnicity for Black and Hispanic populations, respectively; and 
those patients classified using unstructured data were more underserved (lower poverty 
level, higher disease burden.) As a result, our findings may underestimate the disparities 
in opportunity moving for Hispanic and Black children.  Lastly, ORs for children with 
missing race/ethnicity data were stronger than for Other race/ethnicity children. We 





that warrants further research, but is often not included in analyses.       
Implications for population health practice: While our study did not assess 
relationships between health outcomes and residential mobility, the contextualized 
residential mobility metrics that we explored revealed more nuanced racial/ethnic 
disparities in mobility and immobility and may be particularly useful metrics to generate 
within the EHR to characterize vulnerable populations and strengthen medical care. 
While residential moves themselves have not been shown to negatively impact health and 
clinicians have limited influence on their patients’ socioeconomic status, the literature has 
demonstrated that the relationship between childhood residential mobility and health risks 
is largely explained by adverse childhood experiences (ACES).160 Five modifiable 
resilience factors to improve children’s long- and short-term health outcomes have been 
identified along with ten recommendations for pediatricians within clinical practice to 
move toward a trauma-informed medical home.200 The American Academy of Pediatrics 
also underscored the importance of a family-centered medical home in which the social 
determinants of health of families can be addressed and the “2-generation” approach to 
simultaneously helping children and parents can be implemented201,202; by supporting 
parents, research has shown parental involvement (particularly mother involvement) 
protects children from adverse health outcomes in low-income families.203,204 
Implementing an EHR-based population health management tool that “flags” children 
characterized are low opportunity movers can allow for automatic, real-time 
identification of children that may benefit most from case management intervention or 





were in low opportunity census tracts (regardless of moving status), demonstrating the 
need for clinical work to integrate population health placed-based strategies into 
individualized clinical care.205  
Strengths and limitations: Our proposed residential mobility metrics reflect a 
data-driven approach, which results in a number of important limitations. Patient address 
updates in the EHR occur when patients interact with BMC (and not other healthcare 
systems) and associations between decreased continuity of healthcare and residential 
mobility have been documented76—evidence of informed presence. Informed presence is 
likely impacting EHR address data as patients connect to the healthcare system 
intermittently, and if residential instability itself is a health risk factor or poses challenges 
in access to or continuity of care76, EHR address data too are not missing at random. Our 
sample is from New England’s largest safety-net hospital and is the busiest trauma and 
emergency services center in the region. Thus, this concern is slightly attenuated in our 
analytic sample (inclusive of address updates at emergency room visits) because while 
the literature has shown associations between mobility and decreased continuity of care 
in routine primary care, it has also shown associations between mobility or living in a 
shelter and increased emergency care visits76. Our sample is disproportionately skewed 
toward low opportunity movers and non-movers, so the specific distributions and 
associations with race/ethnicity may not generalize to other settings. That said, our study 
focuses on a highly vulnerable population for whom many housing, economic, and social 
policies and programs are intended.  





analytic sample is not comprehensive in nature. Whereas universal healthcare systems 
can track patients across health systems, our analytic sample was built from EHR data 
from BMC’s main hospital only and not its health clinics. Thus, in our open cohort, we 
are unable to account for address changes for patients prior to enrolling at BMC, those 
who visited BMC health clinics, or those who switched to health systems outside BMC’s 
main catchment area during or after their tenure at BMC. Given BMC is a safety-net 
hospital, those enrolling at BMC may be facing hardship (decline in opportunity) and 
those who leave BMC may be experiencing an increase in opportunity, which we do not 
capture in our data. However, we attenuated concerns regarding misclassification of 
movers and non-movers and COI characterization by doing the following: (1) we 
required all patients to have at least 2 visits during the study period and those patients 
who were active at BMC for 2,3,4, and 5 years had at least 2,3,4, and 5 visits across those 
timespans, respectively; (2) we conducted a sensitivity analysis where we excluded 
patients who were only active for 1 year to mitigate concerns about misclassifying non-
movers; (3) we did not analyze mobility at a granular level (number of addresses on file 
due to concerns around addresses not missing at random), but rather analyzed mobility 
more coarsely (mover vs non-mover); (4) our use of the last address on file to 
characterize a patients’ COI was informed by the literature on EHR address data quality 
(indicating the most recent address is the most accurate).75  
Additionally, residential mobility may not be the causal determinant of health 
outcomes; however, this does not detract from the potential uses of mobility metrics for 





has its strengths, it does not reflect the lived experience of patients and their 
motivations/triggers for moving (or not moving.) Research has shown that structural 
racism, operating through residential segregation, contributes to barriers faced by low-
income families in the housing search to areas of opportunity.206–208 Additionally, racial 
and gender discrimination contributes to significant racial/ethnic and gender disparities—
across 39 states, Black and Latinx females were found to face the highest rate of eviction 
in America.209 As Desmond (2012) states “In poor black neighborhoods, eviction is to 
women what incarceration is to men”.210 Of particular relevance to our findings is that 
children are a known risk factor for eviction disproportionately impacting single 
mothers.211  
Although our racial/ethnic disparities findings are descriptive and as a result are 
suggestive, they align with disparities well documented in the literature. While our study 
is strengthened by the use of longitudinal data from the EHR, the analyses are cross-
sectional in nature. Lastly, technical capacity and advanced technology varies across 
health institutions and systems. Nonetheless, our findings are timely and contribute to 
local public health initiatives. The City of Boston is working toward dismantling 
structural racism and barriers through a multi-pronged approach. Our work directly 
contributes to the shift toward reporting race and ethnicity data that documents health 
inequities212 by bringing to light that the groups of children with missing or Other 
race/ethnicity are often left out of the equation and conversation. The importance of 
identifying disparities in opportunity through data analyses contributes to the larger 





the power and the limitations of existing data to fully capture individual experiences, 
especially those involving health and opportunity.  
Opportunities for EHR research: Our work revealed the pressing need to 
increase our understanding of EHR address data to improve associated geospatial 
research. We only found one study (with a sample size of 101) on the accuracy of EHR 
address data and it calls for more research on the validity and reliability of these data.186 
In terms of the geospatial processing of EHR addresses, a recent systematic review found 
several gaps in the current literature on place-based health research using EHR data: 62% 
of EHR-based studies did not report information on methods used to assign geospatial 
data, and only 40% of studies made limited use of historical records of residential 
addresses in the EHR.12 Research on EHR address data is underdeveloped in comparison 
to the breadth and depth of research devoted to purposeful and valid use and 
standardization of EHR health data for research and practice38,41 and the potential for bias 
in EHR health data43 as well as EHR demographic data.199,213–216 One potential issue 
driving the limited progress in place-based health research using EHR data is concerns 
about privacy26 and the particularly sensitive nature of geographic data, though clearly 
there are additional issues including a disconnect with the conventional medical model. 
Interdisciplinary research (population health, data science, informatics, 
geographers/geospatial expertise) is necessary to advance and overcome the current 
limitations of EHR data and answer questions such as: What happens at in-person check-
in (are dummy addresses used to reflect patient refusal or homelessness and do these vary 





afford care? How well do data capture individuals who move across health systems? How 
does geocoding granularity choice impact exposure misclassification for epidemiologic 
studies? Synthetic EHR data are currently under development by The Office of the 
National Coordinator for Health Information Technology (ONC)25, and investment in 
private-public collaboration to also develop synthetic EHR address data may lead to 
progress. 
Conclusion: This analysis, based in EHR address data, revealed significant 
racial/ethnic disparities in access to neighborhood opportunity that contributes to healthy 
child development among those who are residentially mobile and immobile. Although 
there are limitations and issues of data missing not at random, EHRs contain a wealth of 
current and historical address data and present a real opportunity to advance our 
understanding of the relationship between residential mobility and health, allowing for 
clinical and public health interventions to reduce disparities. Our study demonstrated the 
utility of EHR data for characterizing contextualized residential mobility and immobility 
in a manner that can allow for more refined characterization of a key health risk factor. 
The metrics we developed move beyond questions of whether residential mobility 
matters and toward questions of for whom, when, where and why does residential 
mobility (or immobility) matter94,95,158, and could also linked to datasets to contextualize 






Table 4.1 Proposed residential mobility metrics and opportunities for implementation 
with EHR address data  
Dimension of residential 
mobility  
Opportunity using EHR data Operationalization: 
potential metric(s) 
Frequency of moving Determine moves per time 
period using date-time stamps 




Moving distance  Measure distance between 
chronological EHR addresses 
that have been geocoded  
Categorical: Intra-
neighborhood move vs 
intra-urban move vs 
move to suburb; short vs 
long distance 
Continuous: kilometers 
(as the crow flies); 
driving distance (ArcGIS 
Network Analyst Tool) 
“Highly mobile” 
categorization (i.e., how 
many moves qualifies 
someone as highly 
mobile?) 
Conduct cluster analysis of 
EHR data (data-driven 
approach) to produce 
hypothesis generating 
knowledge to inform a 
theoretically-based 
categorization  
Clusters reveal attributes 
of data-driven groupings 
by number of EHR 
addresses on file  
Context of moving  Characterize moving as 
positive or negative experience 
by linking geocoded EHR 
addresses to neighborhood or 
parcel level measures  
Opportunity moving vs 
low opportunity moving; 
lateral moving; defined 
by Census data or area 
measure indices 
Residential immobility Characterize non-movers by 
linking geocoded EHR 
addresses to (time-varying) 
neighborhood or parcel level 
measures 
Residing in a deprived or 
affluent area defined by 
Census data or area 
measure indices 
Motives/triggers of 
mobility (or immobility) 
Natural Language Processing 
(NLP) of clinician notes for 
subjective/lived experience 
characterization of moving or 
staying 
Qualitative list of 
reasons why moving or 
staying occurred mined 






Table 4.2 Characteristics of pediatric sample seen at BMC between 2013-2017 
(n=56,050) 
 
Average or n 
(IQR or %) 
Movers: average 
or n (IQR or %) 
DEMOGRAPHIC CHARACTERISTICS 
Age during follow-up (years) 8.1 (12.0) 8.1 (10.0) 
Sex   
Female 27,217 (48.6%) 9,466 (48.9%) 
Male 28,833 (51.4%) 9,913 (51.1%) 
Race/ethnicity^^   
Asian 2,016 (3.6%) 510 (2.6%) 
Black 21,608 (38.6%) 8,867 (45.8%) 
Hispanic 2,655 (4.7%) 694 (3.6%) 
Not Recorded 18,852 (33.6%) 6,419 (33.1%) 
Other 1,250 (2.2%) 267 (1.4%) 
White 9,669 (17.3%) 2,622 (13.5%) 
Language spoken at home   
English 36,891 (65.8%) 12,675 (65.4%) 
Non-English 19,159 (34.2%) 6,704 (34.6%) 
ACTIVE PATIENT CHARACTERIZATION  
# years considered ‘active patient’ at BMC 
during follow-up^^  
 
1 year 16,972 (30.3%) 3,183 (16.4%) 
2 years 17,621 (31.4%) 6,128 (31.6%) 
3 years 8,675 (15.5%) 3,909 (20.2%) 
4 years 5,840 (10.4%) 2,854 (14.7%) 
5 years 6,942 (12.4%) 3,305 (17.1%) 
LOCATION BASED CHARACTERISTICS  
Census tract opportunity^^    
Low Opportunity*  44,672 (79.7%) 16,071 (82.9%) 
Opportunity**  11,378 (20.3%) 3,308 (17.1%) 
Moving status   
Non-mover  36,671 (65.4%) N/A 
Mover  19,379 (34.6%) N/A 
Based on the last address on file in the EHR: 
^^bivariate association (movers vs non-movers) significant at p<0.05 
*Living in Low opportunity census tracts are those categorized as Very Low or Low 
Opportunity based on the 2015 state-normed Child Opportunity Index 2.0 (COI) quintiles 
**Opportunity census tracts are those categorized as Moderate, High, or Very High 






Table 4.3 Contextualized residential mobility metrics (n=56,050) 
CONTEXTUALIZED RESIDENTIAL MOBILITY  n % 
  
Non-mover status  
  Low opportunity non-mover 28,601 78.0% 
  Opportunity non-mover 8,070 22.0% 
Mover status 
  Low opportunity moving  16,071 83.0% 







Table 4.4 Racial/ethnic differences in contextualized residential mobility 
CONTEXTUALIZED RESIDENTIAL MOBILITY MODELS * 
Comparison between movers and non-movers 
  MODEL 1: 
odds of moving versus 
not moving (95% CI) 
MODEL 2: odds of 
opportunity moving vs 
remaining in low 
opportunity (95% CI) 
MODEL 3: odds of 
low opportunity 
moving vs remaining 
in opportunity (95% 
CI) 
n 56,050 31,909 24,141 
Asian 0.87 (0.78,0.97)** 0.81 (0.68,0.97)** 1.03 (0.88,1.20) 
Black 1.60 (1.52,1.69)** 0.34 (0.31,0.37)** 9.37 (8.61,10.19)** 
Hispanic 1.21 (1.09,1.33)** 0.21 (0.16,0.27)** 9.57 (7.97,11.49)** 
Not Recorded 1.25 (1.18,1.32)** 0.36 (0.33,0.40)** 4.07 (3.76,4.40)** 
Other 0.86 (0.74,0.99)** 0.43 (0.33,0.56)** 1.96 (1.60,2.41)** 
White  Reference  
Comparison within non-movers  
MODEL 4: odds of remaining in low opportunity vs remaining in 
opportunity (95% CI) 
n 36,671  
Asian 1.48 (1.32,1.66)**  
Black 7.16 (6.66,7.71)**  
Hispanic 9.27 (7.89,10.90)**  
Not Recorded 3.82 (3.58,4.08)**  
Other 2.72 (2.34,3.17)**  
White  Reference 
Comparison within movers 
 MODEL 5: odds of low opportunity moving vs opportunity moving (95% 
CI) 
n 19,379  
Asian 0.84 (0.69,1.02) 
Black 3.66 (3.30,4.06)**  
Hispanic 4.47 (3.44,5.81)** 
Not Recorded 2.83 (2.54,3.14)** 
Other 1.60 (1.19,2.15)** 
White Reference 
*adjusted for # years active patient at BMC during 5-year study period 







Figure 4.1 Anderson, Leventhal, Newman and Dupéré (2014)’s conceptual model of the 




















Table S4.1 Sensitivity analyses: excluding patients active for only 1 year at BMC 
CONTEXTUALIZED MOVING STATUS MODELS * 
Comparison between movers and non-movers 
  odds of moving 
versus not moving 
(95% CI) 
odds of opportunity 
moving vs 
remaining in low 
opportunity (95% 
CI) 
odds of low opportunity 
moving vs remaining in 
opportunity (95% CI) 
n 39,078 20,982 18,096 
Asian 0.84 (0.74-0.96)** 0.82 (0.67,0.99)** 0.96 (0.80,1.15) 
Black 1.57 (1.48,1.67)** 0.33 (0.30,0.37)** 9.77 (8.84,10.79)** 
Hispanic 0.96 (0.84,1.10) 0.16 (0.12,0.23)** 6.18 (4.83,7.91)** 
Not Recorded 1.28 (1.20,1.36)** 0.37 (0.33,0.42)** 4.50 (4.10,4.94)** 
Other 0.76 (0.63,0.91)** 0.40 (0.28,0.55)** 1.66 (1.27,2.16)** 
White Reference 
Comparison within non-movers  
odds of remaining in low opportunity vs remaining in opportunity (95% CI) 
n 22,882  
Asian 1.45 (1.25,1.68)** 
Black 7.94 (7.23,8.72)** 
Hispanic 7.78 (6.18,9.79)** 
Not Recorded 4.31 (3.95,4.70)** 
Other 2.73 (2.19,3.41)** 
White  Reference 
Comparison within movers 
 odds of low opportunity moving vs opportunity moving (95% CI) 
n 16,196     
Asian 0.79 (0.64,0.99)**   
Black 3.65 (3.25,4.09)**     
Hispanic 4.75 (3.33,6.79)**     
Not Recorded 2.78 (2.47,3.13)**     
Other 1.52 (1.06,2.18)**     
White  Reference     
*adjusted for # years active patient at BMC during 5-year study period 






CHAPTER 5. CONCLUSIONS 
The overarching goal of this dissertation was to use big data sources for 
population health practice and research with an explicit focus on data interpretability and 
meaningful use of these data given the unique limitations posed by these data. This 
chapter summarizes the novel approaches and findings from Chapters 2-4 used to achieve 
this goal, and provides a discussion of shared limitations, public health implications, as 
well as directions for future work. Specifically, Chapter 2 aimed to overcome technical 
capacity limitations at the local public health level through collaboration with community 
partners and utilization of small-area estimation synthetic data to inform intervention and 
grantsmanship. Chapters 3 and 4 aimed to utilize EHR health data and EHR address data, 
respectively, to create empirically and theoretically based standardized classifications 
(pediatric asthma severity and residential mobility) for use in EHR-based health 
initiatives and studies.  
Chapter summaries 
Chapter 2: Community partner-engaged modeling of geographic and demographic 
patterns of multiple public health risk factors  
 The aim of Chapter 2 was to connect small-area estimation synthetic data with 
high-priority needs articulated by community partners in a fully collaborative context to 
further local public health practice. This work addressed a data gap at the local public 
health level: characterization of patterns of risk factors at a resolution that is meaningful 
to community-level public health efforts. This study focused on the city of New Bedford, 





MA EJ criteria (i.e., low median household income, high percentage of minority or 
limited English proficiency.103   
We collaboratively identified high-priority behaviors and health outcomes of 
interest to our community partners (NorthStar Learning Centers and the City’s Office of 
Environmental Stewardship) available in the Behavioral Risk Factor Surveillance System 
(BRFSS). We then developed multivariable regression models from the BRFSS 
explaining variability in exercise, fruit and vegetable consumption, body mass index, and 
diabetes prevalence as a function of demographic and behavioral characteristics, and 
linked these models with population microdata developed using spatial microsimulation 
to characterize high-risk populations and locations. We found individuals with lower 
income and educational attainment had lower rates of multiple health-promoting 
behaviors (e.g., fruit and vegetable consumption and exercise) and higher rates of self-
reported diabetes. We identified census tracts with an elevated percentage of high-risk 
subpopulations, information our community partners used to prioritize funding and 
intervention programs. 
To our knowledge, this is the first application that has directly connected spatial 
microsimulation methods with high-priority needs articulated by the community in a fully 
collaborative context. While previous studies within the US and internationally78–82 
provided important insights at a high geographic resolution within a community, these 
spatial microsimulation methods have not typically been developed or applied to respond 
directly to community members’ or community-serving organizations’ needs. 





other research groups, pre-dates CDC’s innovative 500 Cities and PLACES projects.77 As 
of December 2020, the PLACES Projects provided access to high quality, small area 
synthetic data on 27 measures related to chronic disease for the entirety of the US using 
the same publicly available data sources as this study.  
Chapter 3: Developing and evaluating a pediatric asthma severity computable 
phenotype derived from electronic health records 
Chapter 3 builds upon a validated and published asthma computable phenotype90,91 to 
create a standardized computable phenotype that is based in clinical asthma guidelines for 
asthma severity.92,93 Standardized ascertainment of asthma severity status from EHR data 
is important to tackle because asthma severity is integral to an asthma diagnosis and 
treatment plan in the clinical setting as well as a key element of valid and interpretable 
research. We also evaluated our phenotype and added important knowledge to the 
literature by examining the impact of the relatively novel concept of informed presence 
on these data from children seen at BMC. Informed presence is a non-traditional source 
of bias inherent to EHRs in which subjects in EHRs are not random but rather are 
reflective of their interactions with and data documentation within the healthcare system 
and are systematically different from people not captured in HER systems.43   
We found that the asthma severity computable phenotype performed as expected in 
comparison to national statistics and the literature. Severity classification for a child was 
maximized when based on the long-term medication regimen component and minimized 
when based only on the symptom data component. In regard to the impact of informed 





severity ascertainment and documentation of lung function testing. Children for whom 
severity could be ascertained from these EHR data were more likely to be seen for 
asthma in the outpatient setting, and less likely to be older or Hispanic. Black children 
were less likely to have lung function testing data present. 
Asthma severity is relevant to advancing risk prediction of asthma morbidity and 
mortality86–89 and to reduce racial/ethnic disparities among children with asthma.149 This 
study extended the current science of mainly binary phenotypes (e.g., asthmatic versus 
non-asthmatic)136 by creating a multi-class computable phenotype for asthma severity. 
Use of the severity phenotype results in better, clinically-grounded classification for use 
in EHR-based health initiatives and studies. 
Chapter 4: Characterizing residential mobility and immobility using address data 
from electronic health records: challenges and opportunities  
 EHR systems have the potential to support our ability to characterize residential 
mobility in more nuanced ways as they are sources of health data and address data. In 
Chapter 4, we aimed to enrich the conceptualization and operationalization of residential 
mobility in the health literature using EHR address data, and we identified the 
opportunities and challenges this data source presents. While the association between 
residential mobility in childhood and health has been studied for several decades76, this 
study filled a gap in the literature: there is growing recognition in the social and 
geographical sciences that scholars can re-conceptualize definitions of residential 
mobility to advance our understanding of its impact on health and well-being.94,95,157,158  





immobility alongside neighborhood opportunity (contextualized mobility metrics) in 
relation to demographic characteristics on children seen at BMC. EHR address data 
revealed significant racial/ethnic disparities in access to neighborhood opportunity that 
contributes to healthy child development. Using definitions of neighborhood opportunity 
derived from the Child Opportunity Index 2.0, we found Hispanic and Black children 
were significantly more likely to experience low opportunity moving compared to White 
children. Among children who moved during our study period, Hispanic and Black 
children are significantly more likely to move to or within low opportunity 
neighborhoods. Among non-movers, Hispanic and Black children are much more likely 
to live in low opportunity neighborhoods. 
Recent studies in the health literature from countries with national, single payer 
health systems have examined associations between health outcomes and expanded 
definitions of residential mobility.177–179 This study adds to the health literature proposing 
residential mobility metrics and methods that draw from the social, geospatial, and data 
science fields and identifies opportunities and limitations associated with using data 
derived from the EHR to explore associations between residential mobility and health 
outcomes in future studies. Additionally, to our knowledge, this is the first study to assess 
the context dimension of residential mobility among children using EHR data.  
Limitations 
 This dissertation is not without limitations, some of which are shared across 
Chapters (see Chapters 2-4 for a detailed discussion of study-specific limitations.) The 





results; however, results in Chapters 2 and 3 were evaluated to attenuate this concern. In 
Chapter 2, we compared our aggregated predictions of city-wide measures to BRFSS data 
for the city and the state to evaluate the internal consistency of our models. A guiding 
question central to this dissertation research was: is the veracity of this data appropriate 
(or not appropriate) to achieve the goal(s) of this public health study? Examination of our 
models for internal consistency (as opposed to a robust, external validation) was 
considered adequate given the purpose of our work with our community partners in 
Chapter 2 was to transform their proposed interventions and/or programs in grant 
applications into data-driven interventions and/or programs. In Chapter 3, our 
computable phenotype produced a distribution and behaved as expected in comparison to 
the literature and national statistics. Validation by clinically assessed (“gold standard”) 
chart review is a well-developed area of research and a component of building a valid 
computable phenotype for use across EHRs.217 While the qualitative evaluation we 
conducted was sufficient to support our study which examined the impact of 
unstandardized and inconsistent EHR data, widespread utilization of the computable 
phenotype would be inappropriate without a validation study. Lastly, in Chapter 4, we 
discovered research on EHR address data is severely lacking and pales in comparison to 
the breadth and depth of research devoted to purposeful, valid, and standardized use of 
EHR health data for research and practice38,41 and the potential for bias in EHR health 
data43 as well as EHR demographic data.199,213–216 We used the last address on file to 
determine our residential mobility metrics based off of the one study in the literature on 





residential mobility metrics that required more granular analysis to attenuate this concern. 
Nonetheless, as demonstrated by the current pandemic, big data fill an important gap in 
public health practice and research when traditional data sources do not exist, are not 
timely, or are too-costly; validation of results remains an ongoing challenge inherent to 
the use of big data in research218.  
Geospatial data and analysis were central to the work conducted in Chapters 2 and 
4. In Chapter 2, we generated area measures of exercise, fruit or vegetable consumption, 
and diabetes rates at the census tract level and in chapter 4, we characterized 
neighborhood opportunity using the Child Opportunity Index 2.0, which is a composite 
measure of 29 data indicators at the census tract level. Our findings from Chapters 2 and 
4 provide key data to inform decision-making or decision support tools in the community 
and clinical setting, respectively; however, all findings in this dissertation were produced 
by data-driven approaches and at a scale that may not reflect the individual’s lived 
experience in their city or neighborhood. Spatial proximity does not imply access; for 
example, relevant to Chapter 2, social environments impact the use of neighborhood 
parks219 and relevant to Chapter 4, inner-city children do not often attend school in their 
neighbhorhood.220 Lastly, the use of census tracts to define neighborhoods may be 
different from and less meaningful to health outcomes than use of individuals’ perceived 
neighborhood.221   
Public health implications 
Create systems change for health equity by leveraging the EHR system itself 





nationwide to create standardized and interoperable infrastructure to improve patient 
healthcare (i.e., quality, safety, and efficiency) through incentive payments, this 
infrastructure can be further standardized and curated to contribute to population health 
practice and research. The main challenge of this dissertation, to work within the 
limitations inherent to big data to extract meaningful knowledge from these data, turned 
out to be an opportunity to engage in solutions-oriented research and do work that, to 
quote Aristotle, “…is greater than the sum of its parts”. In Chapter 2, we combined 
synthetic and publicly available data to responds to community partners’ needs, but at a 
larger and less tangible level, we engaged in bi-directional work in which power is 
shared between researchers and communities. In Chapters 3 and 4, we combined 
individual-level EHR data with rich data sources that already reflect significant and 
meaningful knowledge that has undergone years of refinement by experts (i.e., NHLBI 
clinical asthma guidelines and the Child Opportunity Index 2.0.)  
Chapters 3 and 4 can be considered first pass attempts at auto-identification of 
high-risk subpopulations of children attending one of the nation’s premier safety-net 
hospitals. By integrating knowledge gained from rich, high-quality data external to the 
EHR directly into the EHR, the US healthcare system could become a powerful source of 
knowledge upon which to base EHR population health decision support tools that target 
real-time patient identification and intervention in a manner that is low resource intense, 
minimizes clinician burden, and is systems-oriented (i.e., involves registration staff and 
referrals to social services, legal services, etc.) 





staff, the address they provide could hit against a database that verifies their address 
(much like Amazon does when a consumer places an order online.) If the address differs 
from the last time the patient checked-in, the address could hit against the COI 2.0 
database and inform the appointment clinician with a pop-up box in the EHR. The 
address could also hit against several other databases (such as parcel level databases 
curated to assess mold risk, rodent risk, heat risk/lack of air conditioning during a heat 
wave) to auto-generate referrals to housing, legal, or fuel assistance services and/or to 
auto-fill an EHR resource template sheet and print out for the patient. Such tools could 
have a systemic impact on healthcare and as a result, may improve health equity and 
combat structural racism among some of the most vulnerable children in the US.  
Contribution to the movement toward antiracist research and practice framework 
While the use of big data in this dissertation is timely given its role in the fight 
against the current pandemic, the findings from Chapters 3 and 4 are particularly timely 
in regard to the renewed fight for racial equity that has swept the country. In 2020, we 
witnessed a national movement toward recognizing racism as a persistent barrier to health 
equity. At the national level, the American Medical Association’s recent policy 
recognizes that without systemic changes, racism will continue to negatively impact and 
exacerbate inequities in medicine and public health.222 Within the City of Boston, the 
Mayor issued an executive order on June 12, 2020 declaring racism an emergency, 
designation $4 million to fund eight key strategies to combat racism as a public health 
crisis, of which data availability on racialized health inequities is central to three 





as Boston City Hospital, which as a safety-net hospital serves the most vulnerable in the 
City and the New England region. Laid out in the following paragraph, our findings in 
combination with findings in the literature, directly respond to the Mayor’s call to 
strengthen our collective understanding by documenting and highlighting disparities with 
data to address root causes that cause health inequities.  
The racial/ethnic disparities we found in Chapters 3 and 4 among children seen at 
BMC provide evidence of structural racism in asthma healthcare and access to 
opportunity neighborhoods that foster healthy child development. Place these finding in 
the larger context: the literature is beginning to explicitly document the associations 
between the structural racism of historic redlining and health outcomes and the racialized 
health inequities of today.198 In Chapter 4, we found significant racial/ethnic disparities in 
access to opportunity neighborhoods that highlight the perpetuation of residence in low 
opportunity areas particularly among Black and Hispanic children seen at BMC based on 
EHR address data. In Chapter 3, we analyzed a sub-set of these children seen at BMC, 
children with asthma, and uncovered further racial/ethnic disparities. We found that 
Hispanic children were less likely to have data documented in the EHR on asthma 
severity and that Black children were less likely to have undergone lung function testing. 
Turning to the literature and drilling down even further, we find that lung function 
measures are race-corrected in research and practice despite the fact that race is a social 
construct and not biological construct.224 This correction is built directly into the 
commercially instrument used to measure lung function, the spirometer, and the 





of Blacks.225 Recently, scientists and practitioners have begun to ask what the 
consequences of such corrections may have as drivers of health inequities.226,227 Layering 
the findings from this dissertation with the broader literature clearly illustrates the 
compounding nature of structural racism, and this work responds to the current call to 
conduct antiracist public health research that furthers the health for all.  
Directions for future work  
To advance population health practice and reduce health disparities, the 
development and testing of EHR population health decision support tools is an exciting 
area of work to pursue. Real-time integration of information such as the asthma severity 
computable phenotype or residential mobility metrics, into the EHR could be leveraged 
to identify high-risk patient populations for clinical intervention, increased case 
management or connection with social services outside of healthcare. To continue to 
advance our understanding of and the quality of EHR data (health and address data), we 
propose the following natural extensions to the research presented in Chapters 3 and 4: 
validation studies of the asthma severity computable phenotype at BMC and other 
institutions; large scale studies to assess the accuracy and reliability of EHR address data 
(original or synthetic); studies to assess and standardize EHR address data, geocoding, 
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